PROSPECTUS |
Filed Pursuant to Rule 424(b)(4) |
Registration No. 333-281789
Registration No. 333-281848
13,242,963
Shares of Class B Common Stock
Pre-Funded
Warrants to Purchase up to 2,312,594 Shares of Class B Common Stock
Warrants
to Purchase up to 15,555,557 Shares of Class B Common Stock
Placement
Agent Warrants to Purchase up to 1,088,889 Shares of Class B Common Stock
Up
to 18,957,040 Shares of Class B Common Stock Issuable Upon Exercise of the Pre-Funded Warrants,
Warrants and Placement Agent Warrants
RICHTECH
ROBOTICS INC.
This is a reasonable best
efforts public offering of 13,242,963 shares of Class B common stock, par value $0.0001 per share (the “Class B common
stock”), of Richtech Robotics Inc., a Nevada corporation (the “Company”), and warrants (“Warrants”) to purchase
up to an aggregate of 15,555,557 shares of Class B common stock (and the shares of Class B common stock that are issuable from
time to time upon exercise of the Warrants) at a combined offering price of $1.35 per share and accompanying Warrant. We are also offering
to each purchaser whose purchase of shares of Class B common stock in this offering would otherwise result in the purchaser, together
with its affiliates and certain related parties, beneficially owning more than 4.99% of our outstanding Class B common stock immediately
following the consummation of this offering, the opportunity to purchase pre-funded warrants (“Pre-Funded Warrants”) to purchase
up to 2,312,594 shares of Class B common Stock in lieu of shares of Class B common stock that would otherwise result in the purchaser’s
beneficial ownership exceeding 4.99% of our outstanding Class B common stock (or at the election of the purchaser, 9.99%). Each Pre-Funded
Warrant will be exercisable for one share of our Class B common stock. The purchase price of each Pre-Funded Warrant will equal the
price per share at which the shares of Class B common stock are being sold to the public in this offering, minus $0.00001, and the
exercise price of each Pre-Funded Warrant will be $0.00001 per share. This offering also relates to the shares of Class B common
stock issuable upon exercise of any Pre-Funded Warrant and the Warrants sold in this offering. Each share of Class B common stock
and each Pre-Funded Warrant is being sold together with a Warrant to purchase one share of our Class B common stock, at an exercise
price of $1.35 per share. The Warrants will be exercisable immediately and will expire five years from the date of issuance. The shares
of Class B common stock and Pre-Funded Warrant, and the accompanying Warrants, can only be purchased together in this offering but
will be issued separately and will be immediately separable upon issuance.
There is no established public
trading market for the Warrants or the Pre-Funded Warrants, and we do not expect a market to develop. We do not intend to apply for listing
of the Warrants or the Pre-Funded Warrants on any securities exchange or other nationally recognized trading system. Without an active
trading market, the liquidity of the Warrants and the Pre-Funded Warrants will be limited.
We have engaged Rodman &
Renshaw LLC (the “Placement Agent”) to act as our exclusive placement agent in connection with this offering. The Placement
Agent has agreed to use its reasonable best efforts to arrange for the sale of the securities offered by this prospectus. The Placement
Agent is not purchasing or selling any of the securities we are offering and the Placement Agent is not required to arrange the purchase
or sale of any specific number or dollar amount of securities. We have agreed to pay to the Placement Agent the Placement Agent fees set
forth in the table below, which assumes that we sell all of the securities offered by this prospectus. There is no arrangement for funds
to be received in escrow, trust or similar arrangement. There is no minimum number of shares of securities or minimum aggregate amount
of proceeds that is a condition for this offering to close. We may sell fewer than all of the securities offered hereby, which may significantly
reduce the amount of proceeds received by us, and investors in this offering will not receive a refund if we do not sell all of the securities
offered hereby. Because there is no escrow account and no minimum number of securities or amount of proceeds, investors could be in a
position where they have invested in us, but we have not raised sufficient proceeds in this offering to adequately fund the intended uses
of the proceeds as described in this prospectus. We will bear all costs associated with the offering. See “Plan of Distribution”
on page 33 of this prospectus for more information regarding these arrangements.
We will have a single closing
for all securities purchased in this offering and the combined public offering price per share of Class B common stock (or Pre-Funded
Warrant in lieu thereof) and accompanying Warrant will be fixed for the duration of this offering. We will deliver the securities to be
issued in connection with this offering delivery versus payment or receipt versus payment, as the case may be, upon receipt of investor
funds received by us.
Our Class B common stock is
listed on the Nasdaq Capital Market under the symbol “RR.” On August 28, 2024, the last reported sale price of our Class B
common stock on the Nasdaq Capital Market was $1.45 per share.
You should read this prospectus,
together with additional information described under the headings “Incorporation of Certain Information By Reference” and
“Where You Can Find More Information,” carefully before you invest in any of our securities.
We are an “emerging
growth company” as that term is used in the Jumpstart Our Business Startups Act of 2012 and a “smaller reporting
company”, and as such, we have elected to take advantage of certain reduced public company reporting requirements for this prospectus
and future filings. Investing in our Class B common stock involves a high degree of risk. See “Risk Factors” beginning
on page 12 of this prospectus for a discussion of information that should be considered in connection with an investment in our Class B
common stock. See “Prospectus Summary — Implications of Being an Emerging Growth Company” and
“Prospectus Summary – Implications of Being a Smaller Reporting Company.”
Investing
in our securities involves a high degree of risk. See the section entitled “Risk Factors” beginning on page 12 of
this prospectus and in the documents incorporated by reference into this prospectus for a discussion of risks that should be considered
in connection with an investment in our securities.
| |
Per Share and Accompanying Warrant | | |
Per Pre-Funded Warrant and Accompanying Warrant | | |
Total | |
Combined public offering price | |
$ | 1.3500 | | |
$ | 1.34999 | | |
$ | 20,999,978.82 | |
Placement agent fees(1) | |
$ | 0.0945 | | |
$ | 0.09450 | | |
$ | 1,470,000.14 | |
Proceeds to us, before expenses(2) | |
$ | 1.2555 | | |
$ | 1.25549 | | |
$ | 19,529,978.68 | |
(1) |
Represents a cash placement commission to the
Placement Agent equal to 7.0% of the gross proceeds raised in this offering. We have also agreed to reimburse the Placement Agent
for its legal fees and expenses and other out-of-pocket expenses in an amount of $80,000, and for its clearing expenses in the
amount of $15,950. In addition, we have agreed to issue to the Placement Agent, or its designees, warrants (the “Placement
Agent Warrants”) as compensation in connection with this offering to purchase a number of shares of our Class B common stock
equal to 7.0% of the aggregate number of shares of Class B common stock and Pre-Funded Warrants being offered at an exercise price
equal to 125% of the combined public offering price per share of Class B common stock and accompanying Warrant. See “Plan
of Distribution” for additional information about the compensation payable to the Placement Agent. |
(2) |
Because there is no minimum number of securities or amount of proceeds required as a condition to closing in this offering, the actual public offering amount, Placement Agent fees, and proceeds to us, if any, are not presently determinable and may be substantially less than the total maximum offering amounts set forth above. We estimate the total expenses of this offering payable by us, excluding the Placement Agent fees, will be approximately $374,251. The amount of proceeds to us presented in this table does not give effect to any exercise of the Warrants offered hereby. |
The delivery of the securities to purchasers is expected to be made
on or about September 3, 2024, subject to the satisfaction of customary closing conditions.
Neither
the Securities and Exchange Commission nor any state securities commission has approved or disapproved of these securities or passed
upon the adequacy or accuracy of this prospectus. Any representation to the contrary is a criminal offense.
Rodman
& Renshaw LLC
The date of this prospectus is August 29, 2024.
TABLE
OF CONTENTS
ABOUT
THIS PROSPECTUS
This prospectus is part of a registration statement that we have filed
with the Securities and Exchange Commission (the “SEC”). We incorporate by reference important information into this prospectus.
You may obtain the information incorporated by reference without charge by following the instructions under “Where You Can Find
More Information.” This prospectus contains summaries of certain provisions contained in some of the documents described herein,
but reference is made to the actual documents for complete information. All of the summaries are qualified in their entirety by the actual
documents. Copies of some of the documents referred to herein have been filed or incorporated by reference as exhibits to the registration
statement of which this prospectus forms a part, and you may obtain copies of those documents as described below. You should carefully
read this prospectus as well as additional information described under “Incorporation of Certain Information by Reference,”
before deciding to invest in our securities.
We
have not, and the Placement Agent has not, authorized anyone to provide any information or to make any representations other than those
contained in this prospectus or in any free writing prospectuses prepared by or on behalf of us or to which we have referred you. We
take no responsibility for, and can provide no assurance as to the reliability of, any other information that others may give you. This
prospectus is an offer to sell only the securities offered hereby, and only under circumstances and in jurisdictions where it is lawful
to do so. The information contained in this prospectus or in any applicable free writing prospectus is current only as of its date, regardless
of its time of delivery or any sale of our securities. Our business, financial condition, results of operations and prospects may have
changed since that date.
The
information incorporated by reference or provided in this prospectus contains statistical data and estimates, including those relating
to market size and competitive position of the markets in which we participate, that we obtained from our own internal estimates and
research, as well as from industry and general publications and research, surveys and studies conducted by third parties. Industry publications,
studies and surveys generally state that they have been obtained from sources believed to be reliable. While we believe our internal
company research is reliable and the definitions of our market and industry are appropriate, neither this research nor these definitions
have been verified by any independent source.
For
investors outside the United States: We have not, and the Placement Agent has not, done anything that would permit this offering or possession
or distribution of this prospectus in any jurisdiction where action for that purpose is required, other than in the United States. Persons
outside the United States who come into possession of this prospectus must inform themselves about, and observe any restrictions relating
to, the offering of the securities and the distribution of this prospectus outside the United States.
This
prospectus and the information incorporated by reference into this prospectus contain references to our trademarks and to trademarks
belonging to other entities. Solely for convenience, trademarks and trade names referred to in this prospectus and the information incorporated
by reference into this prospectus, including logos, artwork, and other visual displays, may appear without the ® or TM symbols, but
such references are not intended to indicate, in any way, that we will not assert, to the fullest extent under applicable law, our rights
or the rights of the applicable licensor to these trademarks and trade names. We do not intend our use or display of other companies’
trade names or trademarks to imply a relationship with, or endorsement or sponsorship of us by, any other company.
In
this prospectus, unless the context otherwise requires, the terms “we,” “us,” “our,” “Richtech”
and the “Company” refer to Richtech Robotics Inc.
CAUTIONARY
NOTE REGARDING FORWARD-LOOKING STATEMENTS
This
prospectus, and any documents we incorporate by reference, contain “forward-looking statements” (within the meaning of Section
27A of the Securities Act of 1933, as amended, or the Securities Act, and Section 21E of the Securities Exchange Act of 1934, as amended,
or the Exchange Act) that involve risks and uncertainties. You should not place undue reliance on these forward-looking statements. Our
actual results could differ materially from those anticipated in the forward-looking statements for many reasons, including the reasons
described in our “Prospectus Summary” and “Use of Proceeds” sections in this prospectus and “Risk
Factors,” “Management Discussion and Analysis of Financial Condition and Result of Operations,” and “Business”
sections in Amendment No. 1 to our Annual Report on Form 10-K/A for the year ended September 30, 2023 (the “2023 Annual
Report”), which is incorporated by reference herein. In some cases, you can identify these forward-looking statements by terms
such as “anticipate,” “believe,” “continue,” “could,” “depends,” “estimate,”
“expects,” “intend,” “may,” “ongoing,” “plan,” “potential,” “predict,”
“project,” “should,” “will,” “would” or the negative of those terms or other similar
expressions, although not all forward-looking statements contain those words.
Our
operations and business prospects are always subject to risks and uncertainties including, among others:
| ● | Our
ability to secure raw materials and components to manufacture sufficient quantities of robots
to match demand; |
| ● | Our
ability to secure enterprise clients and deals in the face of growing competition; |
| ● | Assumptions
around the speed of robotic adoption in service environments; |
| ● | Assumptions
relating to the size of the market for our products and services; |
| ● | Unanticipated
regulations of robots and automation that add barriers to adoption and have a negative effect
on our business; |
| ● | Our
ability to obtain and maintain intellectual property protection for our products; and |
| ● | Our
estimates of expenses, future revenue, capital requirements and our needs for, or ability
to obtain, additional financing. |
The
forward-looking statements in this prospectus represent our views as of the date of this prospectus. We anticipate that subsequent events
and developments will cause our views to change. However, while we may elect to update these forward-looking statements at some point
in the future, we have no current intention to do so except to the extent required by applicable law. You should, therefore, not rely
on these forward-looking statements as representing our views as of any date subsequent to the date of this prospectus.
PROSPECTUS
SUMMARY
This
summary highlights selected information that is presented in greater detail elsewhere in this prospectus. This summary does not contain
all of the information you should consider before investing in our securities. You should read this entire prospectus, including
the information incorporated by reference herein, carefully, including the sections titled “Risk Factors” and “Management’s
Discussion and Analysis of Financial Condition and Results of Operations” and our consolidated financial statements and the related
notes included in our 2023 Annual Report, before making an investment decision. This prospectus and the information incorporated
herein by reference include trademarks, service marks and trade names owned by us or other companies. All trademarks, service marks and
trade names included or incorporated by reference into this prospectus and the information incorporated herein by reference are the property
of their respective owners.
Overview
We
are a developer of advanced robotic technologies focused on transforming labor-intensive services in hospitality and other sectors currently
experiencing unprecedented labor shortages. With a global R&D team based out of China and the United States, we design, manufacture
and sell robots to restaurants, hotels, hospitals, senior living centers, casinos, factories, movie theaters and other businesses. Our
robots perform a variety of services including restaurant running and bussing, hotel room service and linen delivery, hospital specialized
deliveries, floor scrubbing and vacuuming, and beverage and food preparation. We design our robots to be friendly, customizable to client
environments, and extremely reliable. For example, our food service delivery robots typically make over 1,000 deliveries every month
in busy environments, while robots working in hospitals make more than 8,000 multi-floor deliveries per month. Our current customer base
includes major hotel brands, national chain restaurants, prestigious hospitals, leading senior care facilities, and top casino management
companies.
Our
mission is to integrate robotics and automation into our everyday lives. We envision ourselves becoming a leading robotics “Super-operator,”
where thousands of our robots are deployed out in the field and managed by Richtech’s AI Cloud Platform (“ACP”). As
a Super-operator, our robotic fleet will be performing a wide variety of tasks within a business, from completing deliveries and scrubbing
floors to cooking noodles and preparing drinks. Our ACP platform will allow businesses to plug in their robots and immediately leverage
an immense amount of data to optimize workflows, lower management complexity, and minimize labor dependency.
On
November 21, 2023, the Company consummated its initial public offering of 2,100,000 shares of Class B common stock at a price
of $5.00 per share, generating gross proceeds of $10.5 million. On December 22, 2023, the underwriters purchased an additional
42,563 shares of Class B common stock at a price of $5.00 per share, generating gross proceeds of $212,815. On November 17,
2023, the shares of Class B common stock began trading on the Nasdaq Capital Market (“Nasdaq”) under the trading symbol
“RR.”
In
connection with the initial public offering, the Company issued to the representative of the underwriters and its designee (the “Representative”)
warrants (the “Representative’s Warrants”) to purchase 105,000 shares of Class B common stock. In connection with
the partial exercise of the underwriters’ over-allotment option, the Company issued to the Representative and its designee additional
Representative’s Warrants to purchase 2,128 shares of Class B common stock. The Representative’s Warrants are exercisable
at a per share exercise price equal to $6.00 at any time and from time to time, in whole or in part, during the period commencing on
May 21, 2024, and terminating on November 21, 2028. Neither the Representative’s Warrants nor any of the shares issued
upon exercise of the Representative’s Warrants may be sold, transferred, assigned, pledged or hypothecated, or be the subject of
any hedging, short sale, derivative, put or call transaction that would result in the effective economic disposition of such securities
by any person, for a period of six (6) months immediately following the commencement of sales of the initial public offering. The
Representative’s Warrants also provides for one demand registration right of the shares underlying the Representative’s Warrants
at the Company’s expense; one additional demand registration at the warrant holders’ expense; and unlimited “piggyback”
registration rights. The registration rights will only be exercisable within a period of five years after November 16, 2023.
The Representative’s Warrants also contain customary anti-dilution provisions.
In
connection with the initial public offering, the Company filed its Second Amended and Restated Articles of Incorporation with the Nevada
Secretary of State on November 17, 2023.
Recent
Developments
Standby
Equity Purchase Agreement
On
February 15, 2024, the Company entered into a Standby Equity Purchase Agreement (the “Purchase
Agreement”) with YA II PN, Ltd. (the “Investor”), pursuant to which
the Investor agreed to purchase up to $50 million of the Company’s shares of Class B common stock over the course of
24 months after the date of the Purchase Agreement. The price of shares to be issued under the Purchase Agreement will be 96% of
the lowest volume weighted average price (the “VWAP”) of the Class B common stock for the three trading days immediately
following the delivery of each Advance notice (as defined below) by the Company (the “Pricing Period”). Each issuance and
sale by the Company to the Investor under the Purchase Agreement (an “Advance”) is subject to a maximum amount equal to 100%
of the daily trading volume of the Class B common stock, as reported by Bloomberg L.P., during the five trading days immediately
preceding an Advance notice.
With
respect to each Advance, the Company has the option to notify the Investor of a minimum acceptable price (“MAP”) by specifying
the amount within an Advance notice. During any trading day within a Pricing Period, two conditions will trigger an automatic reduction
to the amount of the Advance by one-third: either (i) the VWAP of the Class B common stock is below the MAP specified in the
Advance notice, or (ii) there is no VWAP available (each such day, an “Excluded Day”). On each Excluded Day, an
automatic one-third reduction is applied to the specified Advance amount in the Advance notice and that day will be excluded from
the Pricing Period.
Each
Advance is subject to certain limitations, including that the Investor cannot purchase any shares that would result in it beneficially
owning more than 4.99% of the Company’s outstanding voting power or number of shares of Class B common stock at the time of
an Advance or acquiring in the aggregate under the Purchase Agreement more than 19.99% of the Company’s outstanding shares of Class B
common stock as of the date of the Purchase Agreement (the “Exchange Cap”). The Exchange Cap will not apply under certain
circumstances, including, where the Company has obtained stockholder approval to issue in excess of the Exchange Cap in accordance with
the rules of Nasdaq or such issuances do not require stockholder approval under Nasdaq’s “minimum price rule.”
The
Purchase Agreement will terminate automatically on the earlier of February 16, 2026 or when the Investor has purchased an aggregate
of $50 million of Class B common stock. The Company has the right to terminate the Purchase Agreement upon five trading
days’ prior written notice to the Investor, subject to certain conditions.
In
connection with and subject to the satisfaction of certain conditions set forth in the Purchase Agreement, the Investor will pre-advance
to the Company up to $3,000,000 of the $50,000,000 commitment amount (a “Pre-Advance”), with each Pre-Advance to be evidenced
by a convertible promissory note (each, a “SEPA Note”). The first Pre-Advance, in the principal amount of $1,000,000, was
advanced February 15, 2024. The second Pre-Advance, in a principal amount of $1,000,000, was advanced on
March 18, 2024. The third Pre-Advance, in the principal amount of $1,000,000, was advanced on April 15, 2024. Each SEPA Note is
subject to a 4% discount on the principal amount of such SEPA Note. Repayment of the SEPA Notes commenced on May 15, 2024, with
subsequent payments made monthly. As of June 30, 2024, the outstanding balance on the Notes was $2,333,000. The SEPA Notes were fully
repaid in July 2024.
Each
SEPA Note will accrue interest on the outstanding principal balance at the rate of 8% per annum and has a maturity date of February 15,
2025 (as may be extended at the option of the Investor). Beginning in May 2024, the Company was
required to pay, on a monthly basis, one-nineth of the outstanding principal amount of each SEPA Note, together with accrued and
unpaid interest, either (i) in cash or (ii) by submitting an Advance notice pursuant to the Purchase Agreement and selling
the Investor shares, or any combination of (i) or (ii) as determined by the Company. The initial repayment was due 90 days
after the issuance of the first SEPA Note, followed by subsequent payments due every 30 days after the previous payment. Unless
otherwise agreed to by the Investor, any funds received by the Company pursuant to the Purchase Agreement for the sale of shares will
first be used to satisfy any payments due under an outstanding SEPA Note.
At
the election of the Investor, all or a portion of the principal, interest, or other amounts outstanding under each SEPA
Note (the “Conversion Amount”) may be converted into shares of Common Stock (the “Conversion
Shares”), equal to: (x) the Conversion Amount, divided by (y) the Conversion Price. “Conversion Price” is defined as
(i) $6.00 per share of Class B common stock, provided however, on May 28, 2024 (the “Reset Date”), the Conversion Price
shall be adjusted (downwards only) to equal the average of the daily VWAPs for the 5 consecutive trading days immediately prior to the
Reset Date, if such price is lower than the Conversion Price then in effect. The Conversion Shares are entitled to the registration rights
set forth in the Purchase Agreement.
On
March 14, 2024, the Company and the Investor entered into a letter agreement (the “Letter Agreement”) to amend the terms
of each SEPA Note as follows: (i)
the Company may redeem early a portion or all amounts (including principal and accrued and unpaid interest) outstanding under the SEPA
Note with at least 10 trading days’ prior written notice by the Company to the Investor.
The outstanding principal balance being redeemed by the Company shall be subject to a 10% cash redemption premium. After receipt
of the Redemption Notice, the Investor shall have 10 trading days to elect to convert all or any portion of the SEPA Note;
and (ii) the Conversion Price shall not be lower than $1.50 per share of Class B common stock.
The
Company paid a subsidiary of the Investor a structuring fee in the amount of $25,000 and in April 2024, issued to the Investor 259,350
shares of Class B common stock (the “Commitment Shares”) as a commitment fee. The Company and the Investor made certain representations
and warranties to each other that are customary for transactions similar to this one, subject to specified exceptions and qualifications.
Each of the Company and the Investor also agreed to indemnify the other.
As
of August 12, 2024, we had issued 9,035,561 shares under the Purchase Agreement and the SEPA Notes (including 259,350 Commitment Shares).
The
foregoing descriptions of the Purchase Agreement and the SEPA Notes and the transactions contemplated thereby are qualified in their
entirety by reference to the full text of the Purchase Agreement and the SEPA Notes, a copy or a form of which are attached hereto as
Exhibits 10.13 and 10.14, respectively, each of which is incorporated herein in its entirety by reference.
In
connection with the execution of the Purchase Agreement (as defined below), the Company entered into two agreements with Revere Securities,
LLC (“Revere”): (i) a financial services agreement, dated as of January 22, 2024 (the “Financial Services Agreement”),
pursuant to which the Company agreed to pay Revere $25,000 per month on an accrual basis for six months, with payments commencing
upon the execution of the Purchase Agreement, for general financial advisory services provided by Revere, and (ii) a finder’s fee
agreement, dated as of January 22, 2024 (the “Finder’s Fee Agreement”), pursuant to which the Company agreed to pay
Revere (a) cash compensation equal to 7% of total proceeds from Pre-Advances (as defined below) raised under the Purchase Agreement,
plus (b) cash compensation equal to 4% of any Advance (as defined below) under the Purchase Agreement, paid upon 3 business days
after the closing of such Advance.
The
foregoing descriptions of the Financial Services Agreement and the Finder’s Fee Agreement are qualified in their entirety by reference
to the full text of the Financial Services Agreement and the Finder’s Fee Agreement, copies of which are attached hereto as Exhibits
10.15 and 10.16, respectively, each of which is incorporated herein in its entirety by reference.
Corporate
History and Structure
The
Company was originally founded as Richtech Creative Displays LLC in Nevada in July 2016. The primary business at the time of incorporation
was product development work related to machine vision used to process video feed and produce usable outputs. Applications of this work
included interactive projection systems, facial recognition applications such as for temperature screening, and eventually environmental
image recognition, obstacle avoidance recognition, and virtual positioning analysis necessary for indoor robot navigation. From 2019
to 2020, we designed, developed, and built indoor delivery robots. In response to COVID, we pivoted to providing temperature screening
robots that utilized AI algorithms to detect a face and pinpoint the location of the forehead to take an accurate temperature measurement.
As fears around COVID subsided and the labor shortage took hold, we pivoted back to providing delivery robots and other service-related
robots.
Richtech
Creative Displays LLC was converted to Richtech Robotics Inc., a Nevada corporation, in June 2022.
To
further support our clients in optimizing the use of ADAM robots and enhancing the efficiency of their operations, we established a wholly-owned
subsidiary, Alphamax Management LLC, in June 2024. Alphamax Management LLC provides business management and operational services to help
our clients better integrate robots into their workflow.
Our
Products and Services
Our
products are categorized into three kinds of service automation: indoor transport and delivery, sanitation, and food and beverage automation.
Our target market is the hospitality sector, which includes restaurants, hotels, casinos, resorts, senior care, hospitals, and movie
theaters. We also plan to leverage our expertise in food automation to bring services directly to the consumer with the ADAM system which
is described below.
The
majority of our robots can be characterized as Autonomous Mobile Robots (“AMRs”), meaning that our robots can understand
and move through its environment independently. AMRs differ from their predecessors, Autonomous Guided Vehicles (“AGVs”),
which rely on tracks or predefined paths and often require operator oversight. Our AMRs understand their environment through an array
of advanced sensors, with the primary sensor being a LiDAR which stands for Light Detection and Ranging. The LiDAR is able to create
a 2D map of the environment by sending out laser pulses and measuring the time it takes to bounce back, similar to sonar but far more
accurate. Secondary sensors such as RGBD cameras that detect color and depth of images, ultrasonic proximity sensors, and standard AI
machine vision that can recognize objects are used in sync to create an in-depth understanding of the robot’s environment. These
sensors, combined with a robust navigation software stack based on AI algorithms, provides our robots the ability to perform dynamic
path planning through their environments.
Our
ACP service is a business optimization tool that allows customers to benefit from the rich operational data generated by the robots.
Each AMR can operate independently in the real world and report data up to the ACP. The ACP can then utilize the data to optimize
workflows, enhance guest experiences, and minimize waste. The ACP will store robot utilization metrics for analyses and reporting, providing
clients with detailed operational data. Lastly, one of the most important features of the ACP is that it allows multiple types of robots
to operate in the same environment, utilizing the same integrations and providing data back to a centralized point.
Indoor
Transport and Delivery
In
the transport and delivery category we have four main product lines, the Matradee line of server assistant robots geared towards restaurants
and restaurant-like environments, the Medbot line designed specifically for hospital deliveries, the Titan line for heavy duty payloads
in central distribution facilities and general hospitality environments, and the Skylark line of service robots customized for hotel
and room service applications.
Matradee
is a robot designed for dining spaces that can be used for bussing, serving, hosting, advertising, and entertaining. For example,
Matradee will transport food from the kitchen to the table where a waiter can come by and serve the guests. The waiter could then load
the Matradee with dirty plates and send it to the dish washing zone in the kitchen. The robot is designed to operate in narrow and busy
environments, navigating around tables and people in order to get to its destination. Matradee was designed to have a large carrying
capacity and to be extremely stable so that it can carry wine glasses and delicate food items without spilling. It can also be used to
greet guests at the reception area and lead them to their table. With a battery life of eight to fourteen-hours between charges, the
Matradee can run for the entire day without taking a break. When multiple robots are deployed in the same space, the robots communicate
over short-range radio waves to coordinate and make way for each other.
Medbot
is designed specifically for secure and efficient deliveries in hospitals and other healthcare spaces. This line of robots is
a rebranding of the Richie/Robbie robotic line, aimed to help customers better associate the robot to specific applications. The robot
has 4 secured compartments that can be configured to deliver items to up to 4 different destinations per trip. Through our ACP, the Medbot
can travel on elevators and through secure doors providing a fully autonomous delivery solution in extremely dynamic environments. The
Medbot has a very robust suite of sensors that allows it to be very nimble and intelligent when navigating around people as well as large
obstructions like hospital beds and trash bins. From our deployments in the field, a fleet of 5 Medbots can make between 8,000 –
9,000 deliveries per month, traveling over 600 miles, with over 600 hours of active runtime between them. This alleviates one of the
toughest tasks on hospital staff, and provides a very strong ROI for the hospital.
Titan
is the newest addition to our delivery robot lineup, adding an option for customers looking for more heavy duty AMR delivery
options. The current version of Titan can carry between 330 - 440 lbs, with additional models able to carry over 1000lbs in development.
Titan was designed with modularity and ease of implementation in mind, as it can lift any rack as long as the rack meets a certain set
of general parameters. This provides Titan with a very large addressable market in and outside the hospitality space. For example, factories
and warehouses can utilize Titan for delivery of large objects over large spaces, up and down elevators and through secure doors. Titan
broadens the applications where we can apply our AMR technology to improve efficiency and solve labor challenges.
Skylark
represents a set of robots that are designed specifically for hotel and applications where room service is an element of the
client’s business. This product’s addressable market primarily consists of hotels, senior living, and apartment buildings.
The design of Skylark revolves around modularity, and adaptability to the environment it is deployed in. The system consists of a base
navigation module and several modular attachments specialized for specific tasks such as delivery or cleaning. Currently, the Skylark
has a cleaning attachment for vacuuming and mopping floors, and a enclosed delivery attachment for room service and package delivery.
Additional attachments are scheduled for release in the future, including a security and laundry attachment. One important element of
Skylark is that all attachments are customized specifically for the hotel environment. This means the design accounts for common issues
such as door width, elevator navigation, and specific low-obstacle avoidance problems not common in other AMR application scenarios.
The modular Skylark robot provides an all-in-one solution that emphasizes ROI and ease-of-use.
Sanitation
DUST-E
is our autonomous commercial cleaning robot product line that features two distinct models, the S and the MX. The original DUST-E
line included three distinct models, we consolidated the robot line to simplify the customer journey and decrease decision making time. The
S is our smaller robot designed to perform routine vacuum and mopping in spaces less than 10,000 sq. ft., such as indoor hard floor
office environments. The MX is for larger spaces up to 500,000 sq ft., tailored to large industrial and commercial spaces such as warehouses,
factories, large hotel floors, event spaces, schools and universities, and department stores.
Food
and Beverage Automation
ADAM
is our food and beverage automation robot. The core concept of ADAM is to develop a fully independent food and beverage business
based entirely on robots and automation. The dual six-degree-of-freedom robotic arms are designed to provide the same level of flexibility
as a human arm, allowing ADAM to easily emulate human movements. We designed ADAM to be friendly and approachable by giving it a white
and round exterior, and designed it to look more like a robot than a human to avoid the “uncanny valley” effect. (The uncanny
valley is a concept that suggests that humanoid objects that imperfectly resemble actual human beings provoke uncanny or strangely familiar
feelings of uneasiness and revulsion in observers. “Valley” denotes a dip in the human observer’s affinity for the
replica, a relation that otherwise increases with the replica’s human likeness.) We have implemented natural language processing
to allow customers to directly speak their orders to the ADAM, providing customers with a cutting-edge beverage ordering experience.
ADAM is currently serving customers at various venues across the country including inside supermarkets, stadiums, hospitals, and coffee
shops across the country.
Our
Industry
Our
product family was designed to provide labor-intensive businesses with robotic automation solutions. We believe hospitality is the most
labor-intensive industry, which is why we have deployed our robots across restaurants, hotels, casinos, hospitals, bars, event spaces,
and senior living homes.
The
nonindustrial service robotics market includes warehouse picker robots, self-driving floor scrubbers, customer service robots, delivery
robots, surgery robots, food harvesting robots for agriculture, underground and underwater inspection robots, security robots, military
defense robots, drug research robots and others. The market is currently in the phase where end-users and system integrators are still
gaining experience in adoption and implementation of nonindustrial service robots. In North America, the primary driver for adoption
is expected to be the ongoing trend to automate menial or non-value-adding-tasks. These tasks include cleaning, transport and delivery,
and food preparation.
Our
Competitive Strengths
We
believe we are one of the current leaders in the service robotics market for the following reasons:
| ● | First
Mover Advantage: The nonindustrial service robotics market has no clearly defined market
leader. Our Matradee robot is one of the earliest restaurant service robots to launch in
the U.S. market, and we believe we are recognized by customers and competitors as an
established brand in the restaurant service robotics space. We believe that there is only
one other competitive product that was launched for room service delivery prior to our Richie
and Robbie (now rebranded as Medbot) being introduced to the market. Based on our extensive
knowledge of the service robotics industry, we believe ADAM to be one of the earliest commercialized
humanoid robots in the U.S. that can be utilized to serve both food and beverages in
a real-world environment. We have not seen any other dual-arm humanoid robot like ADAM with
full AI capabilities that has come to market and been deployed at any scale in the United
States. |
| ● | Reliable
Technology: Our reliable AI navigation and obstacle recognition algorithms provides our
robots with what we believe is best-in-class reliability and performance. |
| ● | Broad
Product Offerings and Synergies: Unlike our competitors that only provide one robot or
one type of robot, we have a breadth of robotic solutions to deploy depending on a client’s
needs. Having a variety of products not only provides clients with a one-stop-shop for their
service robotic needs, it also creates the impression that we are a reliable resource to
consult as they approach the general adoption and implementation of robotic solutions across
different sectors of their business. |
| ● | Distribution:
We have an extensive network of distribution channels with over 30 regional and national
distributors. These distribution partners span across a broad array of sectors including
healthcare, senior living, hotels, and restaurants. |
| ● | Enterprise
Partnerships: We have executed Master Services Agreements (“MSAs”) with several
large enterprise customers (defined as those companies with annual revenues over $1 billion)
that in total represent over 9,000 restaurant and hotels. We have on-going pilot programs
with ten enterprises that represent over 40,000 locations. Our enterprise customers represent
the largest players in the restaurant, hotel, senior living, and casino industries. We believe
our ability to form enterprise level partnerships will be a major differentiating factor
between us and competitors over the next two-three years. |
| ● | Business
Model: We are at the forefront of the U.S. service robotics market. Our robots utilize
cutting edge sensors and algorithms to provide extremely high reliability in uncontrolled
environments, at an affordable cost for customers. Additionally, we are co-developing novel
innovative solutions through our partnerships with dominant industry partners, in sectors
such as healthcare, lodging, senior living, and retail. We are focused on leveraging these
novel innovative solutions through a Robot-as-a-Service model that will provide long-term
recurring revenue for the business. Lastly, as we continue to develop and launch new solutions
in the hospitality service robotics space, we see high upsell potential in leveraging data
collected by our robots to provide valuable insights into a customer’s business. |
| ● | Market
Coverage: We currently provide deployment and maintenance services to the entire continental
United States and Hawaii. We have deployments in 40 states and anticipate adding more
on a monthly basis. Our ability to maximize the addressable market should accelerate the
growth of our business. With a larger market share, we can utilize economies of scale to
better compete against our competitors. |
Our
Strategies
We
intend to establish ourselves as the leading provider of service robotic solutions by developing, manufacturing, and deploying novel
products that address the growing need for automation in the service industry. The key components to our growth strategy include:
| ● | Building
our commercial organization; |
| ● | Penetrate
the hotel market with Medbot and Titan; |
| ● | Launch
and scale our robotics franchise brand; |
| ● | Establish
enterprise partnerships; |
| ● | Penetrate
the education and government markets; and |
See
the section entitled “Business — Our Strategies” included in our 2023 Annual Report for more details.
Intellectual
Property
We
currently have 9 pending patents and 3 approved patents. Additionally, we will continue to file patent applications for our innovative
inventions. We also hold two trademarks and own and operate three domain names.
Summary
of Risks
Our
business is subject to a number of risks and uncertainties. These risks are discussed more fully in “Risk Factors” included
elsewhere in this prospectus and in the section titled “Risk Factors” included in our 2023 Annual Report and our Quarterly
Report on Form 10-Q for the period ended June 30, 2024, filed with the SEC on August 15, 2024 (“June 30, 2024 Form 10-Q”).
Before you make a decision to invest in our Class B common stock, you should carefully consider all of those risks including the
following:
Risks
Related to Our Industry and Business
| ● | We
operate in an emerging market, which makes it difficult to evaluate our business and prospects. |
| ● | We
operate in an emerging industry that is subject to rapid technological change and will experience
increasing competition. |
| ● | Our
business plans require a significant amount of capital. Future capital needs may require
us to sell additional equity or debt securities that may dilute its stockholders. |
| ● | We
have limited experience in operating our robots in a variety of environments. Unforeseen
safety issues with our products could result in injuries to people which could result in
adverse effects on our business and reputation. |
| ● | We
must successfully manage product introductions and transitions in order to remain competitive. |
| ● | Our
international expansion plans, if implemented, will subject us to a variety of risks that
may harm our business. |
| ● | We
rely on third party manufacturers/suppliers, which may increase the risk that we will not
have sufficient quantities of our products or such quantities at an acceptable cost, which
could delay, prevent or impair our development or commercialization efforts. |
Risks
Related to Our Intellectual Property
| ● | If
we fail to protect or enforce our intellectual property or proprietary rights, our business
and operating results could be harmed. |
| ● | In
addition to patented technology, we rely on our unpatented proprietary technology, trade
secrets, designs, experiences, workflows, data, processes, software and know-how. |
| ● | Under
a certain number of our agreements, we are required to provide indemnification in the event
our technology causes harm to third parties. |
Risks
Related to Compliance
| ● | We
may become subject to new or changing governmental regulations relating to the design, manufacturing,
marketing, distribution, servicing, or use of our products, and a failure to comply with
such regulations could lead to withdrawal or recall of our products from the market, delay
our projected revenues, increase cost, or make our business unviable if we are unable to
modify its products to comply. |
| ● | We
may become involved in legal and regulatory proceedings and commercial or contractual disputes,
which could have an adverse effect on our profitability and financial position. |
| ● | We
are subject to, and must remain in compliance with, numerous laws and governmental regulations
across various jurisdictions concerning the manufacturing, use, distribution and sale of
our products. |
General
Risks Associated with Our Company
| ● | Our
limited operating history and evolving business make it difficult to evaluate our current
business and future prospects. |
| ● | If
we were to lose the services of members of our senior management team, we may not be able
to execute our business strategy. |
| ● | We
are currently a small organization and will need to hire additional qualified personnel to
effectively implement our strategic plan, and if we are unable to attract and retain highly
qualified employees, we may not be able to continue to grow our business. |
| ● | We
are an “emerging growth company,” and will be able take advantage of reduced
disclosure requirements applicable to “emerging growth companies,” which could
make our Class B common stock less attractive to investors. |
| ● | We
will incur significantly increased costs as a result of and devote substantial management
time to operating as a public company. |
| ● | Our
management has limited experience in operating a public company. |
Risks
Related the Ownership of Our Class B Common Stock
| ● | An
active trading market for our Class B common stock may not develop or be sustained. |
| ● | The
trading price of our Class B common stock may be volatile, and you could lose all or
part of your investment. |
| ● | Future
sales of our Class B common stock or securities convertible into our Class B common
stock may depress our stock price. |
| ● | Our
failure to meet the continued listing requirements of Nasdaq could result in a delisting
of our Class B common stock. |
| ● | Our
directors, executive officers and principal stockholders have substantial control over us
and could delay or prevent a change of corporate control. |
Risks Related to This Offering
| ● | We
have broad discretion in the use of the net proceeds from this offering and may not use them
effectively. |
| ● | You
will experience immediate and substantial dilution in the net tangible book value per share
of the Class B common stock you purchase. You may also experience future dilution as a result
of future equity offerings. |
| ● | This
is a reasonable best effort offering, no minimum number of securities is required to be sold,
and we may not raise the amount of capital we believe is required for our business plans,
including our near-term business plans. |
| ● | Purchasers
who purchase our securities in this offering pursuant to a securities purchase agreement
may have rights not available to purchasers that purchase without the benefit of a securities
purchase agreement. |
| ● | Resales
of our Class B common stock in the public market during this offering by our stockholders
may cause the market price of our Class B common stock to fall. |
| ● | This
offering may cause the trading price of our Class B common stock to decrease. |
Implications
of Being an Emerging Growth Company
We
qualify as an “emerging growth company,” as defined in the Jumpstart Our Business Startups Act of 2012 (the “JOBS
Act”). For as long as we remain an emerging growth company, we may take advantage of certain exemptions from various reporting
requirements that are applicable to other public companies. These provisions include, but are not limited to:
| ● | being
permitted to have only two years of audited financial statements and only two years
of related selected financial data and management’s discussion and analysis of financial
condition and results of operations disclosure; |
| ● | an
exemption from compliance with the auditor attestation requirement in the assessment of our
internal control over financial reporting pursuant to Section 404 of the Sarbanes-Oxley
Act of 2002, as amended (the “Sarbanes-Oxley Act”); |
| ● | reduced
disclosure about executive compensation arrangements in our periodic reports, registration
statements, and proxy statements; and |
| ● | exemptions
from the requirements to seek non-binding advisory votes on executive compensation or golden
parachute arrangements. |
In
addition, the JOBS Act permits emerging growth companies to take advantage of an extended transition period to comply with new or revised
accounting standards applicable to public companies. We are not choosing to “opt out” of this provision. We will remain an
emerging growth company until the earliest of (i) the last day of the fiscal year following the fifth anniversary of the completion
of this offering, (ii) the last day of the first fiscal year in which our annual gross revenues exceed $1.235 billion,
(iii) the date on which we have, during the immediately preceding three-year period, issued more than $1.0 billion in non-convertible
debt securities and (iv) the end of any fiscal year in which the market value of our Class B common stock held by non-affiliates
exceeds $700 million as of the end of the second quarter of that fiscal year. We have elected to take advantage of certain of the
reduced disclosure obligations in the registration statement of which this prospectus is a part and may elect to take advantage of other
reduced reporting requirements in future filings. As a result, the information that we provide to our stockholders may be different than
you might receive from other public reporting companies in which you hold equity interests.
Implication
of Being a Controlled Company
Our
co-founder and Chief Executive Officer, Zhenwu (Wayne) Huang, beneficially owns 30,308,000 shares of Class A common stock, par value
$0.0001 per share, of the Company (the “Class A common stock”), representing approximately 64.34% of the total voting
power of our issued and outstanding shares of common stock. As a result, we are a “controlled company” as defined under the
Nasdaq rules, because Zhenwu (Wayne) Huang holds more than 50% of the voting power for the election of directors. As a “controlled
company,” we are permitted to elect not to comply with certain corporate governance requirements. If we rely on these exemptions,
you will not have the same protection afforded to stockholders of companies that are subject to these corporate governance requirements.
Implications
of Being a Smaller Reporting Company
We
are a “smaller reporting company” as defined in Item 10(f)(1) of Regulation S-K. Smaller reporting companies may take advantage
of certain reduced disclosure obligations, including, among other things, providing only two years of audited financial statements. We
will remain a smaller reporting company until the last day of any fiscal year for so long as either (1) the market value of our shares
of Common Stock held by non-affiliates does not equal or exceed $250.0 million as of the prior June 30th, or (2) our annual revenues
did not equal or exceed $100.0 million during such completed fiscal year and the market value of our shares of Common Stock held by non-affiliates
did not equal or exceed $700.0 million as of the prior June 30th. To the extent we take advantage of any reduced disclosure obligations,
it may make comparison of our financial statements with other public companies difficult or impossible.
Principal
Offices
Our
principal executive offices are located at 4175 Cameron St, Ste 1, Las Vegas, NV 89103. Our telephone number is (866) 236-3835.
Our website address is www.richtechrobotics.com. The information contained in, or that can be accessed through, our website is
not a part of or incorporated by reference in this prospectus, and you should not consider it part of this prospectus or of any prospectus
supplement. We have included our website address in this prospectus solely as an inactive textual reference.
THE
OFFERING
Class B common stock to be offered |
|
13,242,963 shares. |
|
|
|
Combined offering price per share and accompanying Warrant |
|
$1.35. |
|
|
|
Pre-Funded Warrants offered by us in this offering |
|
We are also offering to each purchaser whose purchase of shares of Class B common stock in this offering would otherwise result in the purchaser, together with its affiliates and certain related parties, beneficially owning more than 4.99% of our outstanding Class B common stock immediately following the consummation of this offering Pre-Funded Warrants to purchase up to 2,312,594 shares of Class B common stock in lieu of shares of Class B common stock that would otherwise result in the purchaser’s beneficial ownership exceeding 4.99% of our outstanding Class B common stock (or at the election of the purchaser, 9.99%). Each Pre-Funded Warrant will be exercisable for one share of our Class B common stock. The purchase price of each Pre-Funded Warrant will equal the price per share at which the shares of Class B common stock are being sold to the public in this offering, minus $0.00001, and the exercise price of each Pre-Funded Warrant will be $0.00001 per share. This offering also relates to the shares of Class B common stock issuable upon exercise of any Pre-Funded Warrants sold in this offering. To better understand the terms of the Pre-Funded Warrants, you should carefully read the “Description of Securities We Are Offering” section of this prospectus. You should also read the form of Pre-Funded Warrant, which has been filed as an exhibit to the registration statement that includes this prospectus. |
|
|
|
Warrants offered by us in this offering |
|
Warrants to purchase up to an aggregate of 15,555,557 shares of our Class B common stock. Each share of our Class B common stock and each Pre-Funded Warrant is being sold together with a Warrant to purchase one share of our Class B common stock. Each Warrant will have an exercise price of $1.35 per share, will be immediately exercisable and will expire on the fifth anniversary of the original issuance date. This prospectus also relates to the offering of the shares of Class B common stock issuable upon exercise of the Warrants. To better understand the terms of the Common Warrants, you should carefully read the “Description of Securities We Are Offering” section of this prospectus. You should also read the forms of Common Warrants, which has been filed as exhibits to the registration statement that includes this prospectus. |
|
|
|
Placement Agent Warrants offered by us in this offering |
|
We have also agreed to issue to the Placement Agent or its designees as compensation in connection with this offering Placement Agent Warrants to purchase up to 1,088,889 shares of Class B common stock. The Placement Agent Warrants an exercise price of $1.6875 per share (equal to 125% of the combined public offering price per share of Class B common stock and accompanying Warrant). The Placement Agents Warrants will be exercisable upon issuance and will terminate on the five (5) year anniversary of commencement of sales in this offering. This prospectus also relates to the offering of the shares of Class B common stock issuable upon exercise of the Placement Agent Warrants. To better understand the terms of the Placement Agent Warrants, you should carefully read the descriptions of the Placement Agent Warrants in the “Description of Securities We Are Offering” and “Plan of Distribution” sections of this prospectus. You should also read the form of Placement Agent Warrant, which has been filed as an exhibit to the registration statement that includes this prospectus. |
|
|
|
Class B common stock outstanding immediately before this offering |
|
37,103,097 shares. |
|
|
|
Class B common stock to be outstanding immediately after this offering |
|
52,658,654 shares, assuming exercise in full of all Pre-Funded Warrants and no exercise of the Warrants and Placement Agent Warrants being offered in this offering. |
Lock-up agreements |
|
Our directors and executive officers have agreed with the Placement
Agent not to offer for sale, issue, sell, contract to sell, pledge or otherwise dispose of any of our common stock or securities convertible
into our common stock for a period of sixty (60) days from the closing of this offering. See “Plan of Distribution”
for additional information. |
|
|
|
Use of proceeds |
|
We estimate that the net proceeds from this offering will be approximately
$19.1 million. We currently intend to use the net proceeds from this offering for working capital, general corporate purposes, including
the further development of our product candidates, and the procurement of inventory, specifically for robotic hardware. See “Use
of Proceeds” for additional information. |
|
|
|
Risk factors |
|
An investment in our securities
involves a high degree of risk. See “Risk Factors” beginning on page 12 of this prospectus and the other information
included and incorporated by reference in this prospectus for a discussion of the risk factors you should carefully consider before
deciding to invest in our securities. |
|
|
|
Reasonable best efforts offering |
|
We
have agreed to offer and sell the securities offered hereby to the purchasers through the Placement
Agent. The Placement Agent is not required to buy or sell any specific number or dollar amount of
the securities offered hereby, but it will use its reasonable best efforts to solicit offers to purchase
the securities offered by this prospectus. See “Plan of Distribution” beginning
on page 33 of this prospectus.
|
|
|
|
Transfer agent and registrar |
|
The transfer agent and
registrar for our Class B common stock is Continental Stock Transfer & Trust Company. |
|
|
|
Nasdaq symbol |
|
Our Class B common stock is listed on Nasdaq under
the symbol “RR.” |
(1) | The
number of shares of Class B common stock to be outstanding after this offering is based
on 37,103,097 shares of our Class B common stock outstanding as of August 12, 2024 and
excludes, as of that date, the following: |
| ● | 107,128
shares of Class B common stock issuable upon the exercise of the Representative’s Warrants; |
| ● | 1,020,874
shares of Class B common stock reserved for future grants of equity-based awards under our
equity incentive plan; and |
| ● | Up
to 3,947,647 shares of Class B common stock issuable under the Purchase Agreement (including
the shares of Class B common stock issuable upon the conversion of the SEPA Notes). |
RISK
FACTORS
An
investment in our securities involves a high degree of risk. You should carefully consider the risks and uncertainties described below,
as well as the risks set forth under the section titled “Risk Factors” in our 2023 Annual Report and our June 30, 2024 Form
10-Q, which are incorporated by reference herein. You should also refer to the other information contained in this prospectus and the
documents incorporated by reference herein, including the section titled “Management’s Discussion and Analysis of Financial
Condition and Results of Operations” and our consolidated financial statements and related notes included in our 2023 Annual Report
and Jund 30, 2024 Form 10-Q, before making a decision to invest in our securities. Our business, operating results, financial condition,
or prospects could be materially and adversely affected by any of these risks and uncertainties. If any of these risks actually occurs,
the trading price of our securities could decline and you might lose all or part of your investment. Our business, operating results,
financial performance, or prospects could also be harmed by risks and uncertainties not currently known to us or that we currently do
not believe are material.
Risks
Related to This Offering
We
have broad discretion in the use of the net proceeds from this offering and may not use them effectively.
Our
management will have broad discretion in the application of the net proceeds, including for any of the purposes described in the section
of this prospectus entitled “Use of Proceeds.” You will be relying on the judgment of our management with regard to
the use of these net proceeds, and you will not have the opportunity, as part of your investment decision, to assess whether the net
proceeds are being used appropriately. The failure by our management to apply these funds effectively could result in financial losses
that could have a material adverse effect on our business, causing the price of our securities to decline and delay the development of
our product candidates, and to repay loans. Pending the application of these funds, we may invest the net proceeds from this offering
in a manner that does not produce income or that loses value.
There
is no public market for the Pre-Funded Warrants or Warrants to purchase Class B common stock in this offering.
There
is no established trading market for the Pre-Funded Warrants or Warrants being offered in this offering, and we do not expect a market
to develop. In addition, we do not intend to apply for listing of the Pre-Funded Warrants or Warrants on any securities exchange. Without
an active market, the liquidity of the Pre-Funded Warrants and Warrants will be limited.
The
Warrants may not have any value.
The Warrants are exercisable at a price of $1.35 per share for a five-year
term from the initial date of issuance. In the event that our Class B common stock price does not exceed the exercise price of the Warrants
during the period when the Warrants are exercisable, the Warrants may not have any value.
Holders
of our Pre-Funded Warrants and Warrants will have no rights as a common stockholder until they exercise their Pre-Funded Warrants and
Warrants.
Until
you receive shares of our Class B common stock as a result of exercising your Warrants or Pre-Funded Warrants, you will have no rights
with respect to our Class B common stock. Upon exercising your Warrants or Pre-Funded Warrants, you will be entitled to exercise the
rights of a common stockholder only as to matters for which the record date occurs after the exercise date.
You
will experience immediate and substantial dilution in the net tangible book value per share of the Class B common stock and accompanying
Warrant you purchase. You may also experience future dilution as a result of future equity offerings.
The price per share, together with the number of shares of our Class
B common stock we propose to issue and ultimately will issue if this offering is completed, may result in an immediate decrease in the
market price of our Class B common stock. Our historical net tangible book value as of June 30, 2024 was $9,079 thousand, or approximately
$0.13 per share of common stock (as defined herein). After giving effect to the 13,242,963 shares of our Class B common stock to be sold
in this offering at a combined public offering price of $1.35 per share and accompanying Warrant, and assuming exercise in full of the
Pre-Funded Warrants to purchase up to 2,312,594 shares of Class B common stock offered hereby, our pro forma as adjusted net tangible
book value as of June 30, 2024 would have been $39,771 thousand, or $0.42 per share of common stock. This represents an immediate increase
in pro forma net tangible book value of $0.31 per share of common stock to our existing stockholders and an immediate decrease in net
tangible book value of approximately $0.93 per share of common stock to new investors, representing the difference between the combined
public offering price and our as adjusted net tangible book value as of June 30, 2024, after giving effect to this offering, and the combined
public offering price per share.
In
addition, in order to raise additional capital, we may in the future offer additional shares of our Class B common stock or other securities
convertible into or exchangeable for our Class B common stock at prices that may not be the same as the price per share in this offering.
In the event that the outstanding options or warrants are exercised or settled, or that we make additional issuances of Class B common
stock or other convertible or exchangeable securities, you could experience additional dilution. We cannot assure you that we will be
able to sell shares or other securities in any other offering at a price per share that is equal to or greater than the price per share
paid by investors in this offering, and investors purchasing shares or other securities in the future could have rights superior to existing
stockholders, including investors who purchase securities in this offering. The price per share at which we sell additional shares of
our Class B common stock or securities convertible into Class B common stock in future transactions, may be higher or lower than the
combined public offering price per share in this offering. As a result, purchasers of the shares we sell, as well as our existing stockholders,
will experience significant dilution if we sell at prices significantly below the price at which they invested.
This
is a reasonable best efforts offering, no minimum amount of securities is required to be sold, and we may not raise the amount of capital
we believe is required for our business plans.
The
Placement Agent has agreed to use its reasonable best efforts to solicit offers to purchase the securities in this offering. The Placement
Agent has no obligation to buy any of the securities from us or to arrange for the purchase or sale of any specific number or dollar
amount of the securities. There is no required minimum number of securities that must be sold as a condition to completion of this offering.
Because there is no minimum offering amount required as a condition to the closing of this offering, the actual offering amount, Placement
Agent fees and proceeds to us are not presently determinable and may be substantially less than the maximum amounts set forth above.
We may sell fewer than all of the securities offered hereby, which may significantly reduce the amount of proceeds received by us, and
investors in this offering will not receive a refund in the event that we do not sell an number of securities sufficient to pursue the
business goals outlined in this prospectus. Thus, we may not raise the amount of capital we believe is required for our business plans
and may need to raise additional funds, which may not be available or available on terms acceptable to us.
Purchasers
who purchase our securities in this offering pursuant to a securities purchase agreement may have rights not available to purchasers
that purchase without the benefit of a securities purchase agreement.
In
addition to rights and remedies available to all purchasers in this offering under federal securities and state law, the purchasers that
enter into a securities purchase agreement will also be able to bring claims of breach of contract against us. The ability to pursue
a claim for breach of contract provides those investors with the means to enforce the covenants uniquely available to them under the
securities purchase agreement including, but not limited to: (i) timely delivery of securities; (ii) agreement to not obtaining any financings
for 60 days from closing; and (iii) indemnification for breach of contract.
Resales
of our Class B common stock in the public market during this offering by our stockholders may cause the market price of our Class B common
stock to fall.
Sales
of a substantial number of shares of our Class B common stock could occur at any time. The issuance of new shares of our Class B common
stock could result in resales of our Class B common stock by our current stockholders concerned about the potential ownership dilution
of their holdings. In turn, these resales could have the effect of depressing the market price for our Class B common stock.
This
offering may cause the trading price of our Class B common stock to decrease.
The
price per share, together with the number of shares of Class B common stock we propose to issue and ultimately will issue if this offering
is completed, may result in an immediate decrease in the market price of our Class B common stock. This decrease may continue after the
completion of this offering.
FINRA
sales practice requirements may limit a stockholder’s ability to buy and sell our Class B common stock.
The
Financial Industry Regulatory Authority (“FINRA”) has adopted rules that require that in recommending an investment to a
customer, a broker-dealer must have reasonable grounds for believing that the investment is suitable for that customer. Prior to
recommending speculative low-priced securities to their non-institutional customers, broker-dealers must make reasonable
efforts to obtain information about the customer’s financial status, tax status, investment objectives and other information. Under
interpretations of these rules, the FINRA believes that there is a high probability that speculative low-priced securities will
not be suitable for at least some customers. The FINRA requirements make it more difficult for broker-dealers to recommend that
their customers buy our Class B common stock, which may have the effect of reducing the level of trading activity in our Class B
common stock. As a result, fewer broker-dealers may be willing to make a market in our Class B common stock, reducing a stockholder’s
ability to resell shares of our Class B common stock.
USE
OF PROCEEDS
We estimate that the net proceeds
from the offering will be approximately $19.1 million, after deducting the Placement Agent fees and estimated offering expenses payable
by us and assuming no exercise of Pre-Funded Warrants and Warrants. However, because this is a reasonable best-efforts offering and there
is no minimum offering amount required as a condition to the closing of this offering, the actual offering amount, the Placement Agent’s
fees and net proceeds to us are not presently determinable and may be substantially less than the maximum amounts set forth on the cover
page of this prospectus. We will only receive additional proceeds from the exercise of the Pre-Funded Warrants, if any, and the Placement
Agent Warrants and Warrants we are issuing in this offering if the Pre-Funded Warrants, Placement Agent Warrants and the Warrants are
exercised for cash. We cannot predict when or if the Pre-Funded Warrants, Placement Agent Warrants or the Warrants will be exercised.
It is possible that these warrants may expire and may never be exercised.
We
currently intend to use the net proceeds from this offering for working capital, general corporate purposes, including the further development
of our product candidates, and the procurement of inventory, specifically for robotic hardware. The strategic investment in our inventory
is aimed at bolstering our capacity to support our Robot-as-a-Service business model. This expected use of proceeds from this offering
represents our intentions based upon our current plans and prevailing business conditions, which could change in the future as our plans
and prevailing business conditions evolve. The amounts and timing of our use of proceeds will vary depending on a number of factors,
including the amount of cash generated or used by our operations. As a result, we will retain broad discretion in the allocation of the
net proceeds of this offering.
CAPITALIZATION
The
following table presents a summary of our cash and cash equivalents and capitalization as of June 30, 2024:
| ● |
on an actual basis;
|
| | |
| ● | on a pro forma basis to give effect to the issuances in July 2024 (i)
of an aggregate of 8,300,000 shares of Class B common stock pursuant to the Purchase Agreement and the receipt by us of approximately
$11,537 thousand in aggregate proceeds and (ii) of an aggregate of 1,273,000 shares of Class B common stock under our equity incentive
plan, in each case subsequent to June 30, 2024 (collectively, the “Pro Forma Adjustments”); and |
| ● | on
a pro forma as adjusted basis to reflect the issuance and sale of Class B common stock and associated Warrant, assuming all Pre-Funded
Warrants are exercised, and after deducting Placement Agent fees and estimated offering expenses payable by us. |
The
unaudited as adjusted information below is prepared for illustrative purposes only and our capitalization following the completion of
this offering will be adjusted based on the actual combined public offering price and other terms of this offering determined at pricing.
You should read the following table in conjunction with “Management’s Discussion and Analysis of Financial Condition and
Results of Operations” and the historical financial statements and related notes in our 2023 Annual Report and our June 30,
2024 Form 10-Q, incorporated herein by reference.
(In thousands, except share and per share data) | |
Actual | | |
Pro Forma | | |
Pro Forma | |
| |
| | |
(unaudited) | | |
(as adjusted) | |
Cash and cash equivalents | |
$ | 9,201 | | |
$ | 20,738 | | |
$ | 39,893 | |
Class B Common stock, $0.0001 par value, 200,000,000 shares authorized, 27,530,097, 37,103,097 and 52,658,654 shares issued and outstanding, actual, pro forma and pro forma, as adjusted, respectively | |
| 0 | | |
| 4 | | |
| 5 | |
Additional paid-in capital | |
| 14,059 | | |
| 25,592 | | |
| 44,746 | |
Accumulated (deficit) | |
| (4,980 | ) | |
| (4,980 | ) | |
| (4,980 | ) |
Total stockholders’ equity | |
$ | 9,079 | | |
$ | 20,616 | | |
$ | 39,771 | |
The
above discussion is based on 27,530,097 shares of our Class B common stock outstanding as of June 30, 2024 and excludes, as of that date,
the following:
| ● | 107,128 shares of Class B common stock issuable upon the exercise of
the Representative’s Warrants; |
| ● | 2,293,874
shares of Class B common stock reserved for future grants of equity-based awards under our
equity incentive plan; and |
| ● | 12,247,647
shares of Class B common stock issuable under the Purchase Agreement (including the shares
of Class B common stock issuable upon the conversion of the SEPA Notes). |
DILUTION
If you purchase our securities
in this offering, your interest will be diluted immediately to the extent of the difference between the combined public offering price
per share you will pay in this offering and the as adjusted net tangible book value per share of our Class A common stock and Class B common stock (together, the “common stock”) after this offering.
Net tangible book value per share represents our total tangible assets less total liabilities, divided by the number of shares of our common stock outstanding.
As of June 30, 2024, our net
tangible book value as of June 30, 2024, was $9,079 thousand, or $0.13 per share of common stock.
After giving effect to the
Pro Forma Adjustments, our net tangible book value was $20,616 thousand, or $0.11 per share of common stock.
After
giving further effect to the sale by us of 13,242,963 shares of Class B common stock and associated Warrant at a combined public offering
price of $1.35 per share, assuming all Pre-Funded Warrants to purchase up to 2,312,594 shares of Class B common stock are exercised,
and after deducting the Placement Agent fees and estimated offering expenses payable by us, our as adjusted net tangible book value as
of June 30, 2024 would have been $39,771 thousand, or $0.42 per share. This represents an immediate increase in pro forma net tangible
book value of $0.31 per share to our existing stockholders, and an immediate dilution of approximately $0.93 per share to purchasers
of shares in this offering, as illustrated in the following table:
Combined public offering price per share | |
| | | |
$ | 1.35 | |
Net tangible book value per share as of June 30, 2024 | |
$ | 0.13 | | |
| | |
Decrease in net tangible book value per share of common stock attributable to the Pro Forma Adjustments | |
$ | 0.02 | | |
| | |
Pro forma net tangible book value per share, as of June 30, 2024 | |
$ | 0.11 | | |
| | |
Increase in pro forma net tangible book value per share of common stock after giving effect to the offering | |
$ | 0.31 | | |
| | |
Pro forma as adjusted net tangible book value as of June 30, 2024 after giving effect to the offering | |
| | | |
$ | 0.42 | |
Dilution in net tangible book value per share to new investors in the offering | |
| | | |
$ | 0.93 | |
The above discussion is based
on an aggregate of 69,683,943 shares of our common stock outstanding as of June 30, 2024 and excludes, as of that date, the following:
|
● |
107,128 shares of Class B common stock issuable upon the exercise of
the Representative’s Warrants; |
|
● |
2,293,874 shares of Class B common stock reserved for future grants of equity-based awards under our equity incentive plan; and |
|
● |
12,247,647 shares of Class B common stock issuable under the Purchase Agreement (including the shares of Class B common stock issuable upon the conversion of the SEPA Notes). |
PRINCIPAL
STOCKHOLDERS
The
following table sets forth certain information concerning the ownership of our Class A common stock and Class B common stock
as of August 12, 2024, with respect to: (i) each person, or group of affiliated persons, known to us to be the beneficial owner
of more than five percent of our Class A common stock and Class B common stock; (ii) each of our directors; (iii) each
of our named executive officers; and (iv) all of our current directors and executive officers as a group.
Applicable
percentage ownership is based on an aggregate of 79,256,943 shares of our common stock, consisting of (i) 42,153,846 shares of our
Class A common stock and (ii) 37,103,097 shares of our Class B common stock outstanding as of August 12, 2024. We
have determined beneficial ownership in accordance with the rules of the SEC. These rules generally attribute beneficial ownership
of securities to persons who possess sole or shared voting or investment power with respect to such securities. In addition, pursuant
to such rules, we deemed outstanding shares of Class B common stock subject to options or warrants held by that person that are
currently exercisable or exercisable within 60 days of August 12, 2024. We did not deem such shares outstanding, however, for the
purpose of computing the percentage ownership of any other person. Except as indicated by the footnotes below, we believe, based on the
information furnished to us, that the beneficial owners named in the table below have sole voting and investment power with respect to
all shares of our Class A common stock and Class B common stock that they beneficially own, subject to applicable community
property laws.
Beneficial
Ownership Table
| |
Prior
to this Offering | | |
After this Offering** | |
Name
of Beneficial Owner(1) | |
Shares
of
Class A
Common
Stock | | |
Shares
of
Class B
Common
Stock | | |
%
of
Total
Voting
Power | | |
Shares
of
Class A
Common
Stock | | |
Shares
of
Class B
Common
Stock | | |
%
of
Total
Voting
Power | |
Executive Officers and Directors | |
| | |
| | |
| | |
| | |
| | |
| |
Zhenwu Huang | |
| 30,308,000 | | |
| — | | |
| 66.08 | % | |
| 30,308,000 | | |
| — | | |
| 61.91 | % |
Zhenqiang Huang | |
| 7,892,000 | | |
| — | | |
| 17.21 | % | |
| 7,892,000 | | |
| — | | |
| 16.64 | % |
Phil Zheng | |
| — | | |
| 1,200,000 | | |
| * | | |
| — | | |
| 1,200,000 | | |
| * | |
Matthew G. Casella | |
| — | | |
| — | | |
| — | | |
| — | | |
| — | | |
| — | |
John Shigley | |
| — | | |
| — | | |
| — | | |
| — | | |
| — | | |
| — | |
Stephen Markscheid | |
| — | | |
| — | | |
| — | | |
| — | | |
| — | | |
| — | |
Saul Factor | |
| — | | |
| — | | |
| — | | |
| — | | |
| — | | |
| — | |
All officers and directors
as a group (7 individuals) | |
| 38,200,000 | | |
| 1,200,000 | | |
| 83.55 | % | |
| 38,200,000 | | |
| 1,200,000 | | |
| 80.81 | % |
5% Stockholders | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | |
King Bliss Limited(2) | |
| 1,734,846 | | |
| 2,200,000 | | |
| 4.26 | % | |
| 1,734,846 | | |
| 2,200,000 | | |
| 4.12 | % |
* | Less
than 1% |
** |
Assumes the sale of 13,242,963 shares of Class B common stock and accompanying
Warrants and full exercise of the 2,312,594 Pre-Funded Warrants. |
| (1) | Unless
noted otherwise, the address of all listed stockholder is 4175 Cameron St Ste 1, Las Vegas,
NV 89103. Each of the stockholder listed has sole voting and investment power with respect
to the shares beneficially owned by the stockholder unless noted otherwise. |
| (2) | Mr.
Zhao Zilong is the sole shareholder and director of King Bliss Limited, a company incorporated
in the British Virgin Islands, and as such, has sole voting and dispositive power over the
securities held by such entity. |
We
are not aware of any arrangement that may, at a subsequent date, result in a change of control of our Company.
DESCRIPTION
OF CAPITAL STOCK
The
following summary of the rights of our capital stock is not complete and is subject to and qualified in its entirety by reference to
our Second Amended and Restated Articles of Incorporation and Amended and Restated Bylaws, copies of which are filed as exhibits to our
2023 Annual Report on Form 10-K, and forms of securities, copies of which are filed as exhibits to the registration statement of which
this prospectus forms a part, which are incorporated by reference herein.
Securities
Pursuant
to our Second Amended and Restated Articles of Incorporation, our authorized capital stock is (a) 310,000,000 shares of
common stock, $0.0001 par value per share, consisting of (i) 100,000,000 shares of Class A common stock and (ii) 200,000,000 shares
of Class B common stock; and (b) 10,000,000 shares of “blank check” preferred stock, par value $0.0001 per share
(“preferred stock”).
Our
board of directors may from time to time authorize by resolution the issuance of any or all shares of the common stock and the preferred
stock authorized in accordance with the terms and conditions set forth in Second Amended and Restated Articles of Incorporation for such
purposes, in such amounts, to such persons, corporations, or entities, for such consideration and in the case of the preferred stock,
in one or more series, all as the board in its discretion may determine and without any vote or other action by the stockholders, except
as otherwise required by law.
Common
Stock
Our Second Amended and Restated
Articles of Incorporation provides for two classes of common stock. As of August 12, 2024, there were 79,256,943 shares of our common
stock issued and outstanding, consisting of 42,153,846 shares of Class A common stock and 37,103,097 shares of Class B
common stock.
Except
as otherwise required by the Nevada Revised Statutes (“NRS”), each holder of Class A common stock is entitled to ten
(10) votes in respect of each share of Class A common stock held by him, her, or it of record on the books of the Company,
and each holder of Class B common stock is entitled to one (1) vote in respect of each share of Class B common stock held
by him, her, or it of record on the books of the Company, in connection with the election of directors and on all matters submitted to
a vote of stockholders of the Company. Each share of Class A common stock is convertible into one share of Class B common stock at any
time at the option of the holder, but Class B common stock shall not be convertible into Class A common stock under any circumstances.
Holders of our common stock do not have preemptive, subscription, or redemption rights.
Standby
Equity Purchase Agreement
On
February 15, 2024, the Company entered into the Standby Equity Purchase Agreement with
YA II PN, Ltd., pursuant to which the Investor agreed to purchase up to $50 million of the Company’s shares of Class B
common stock over the course of 24 months after the date of the Purchase Agreement. The price of shares to be issued under the Purchase
Agreement will be 96% of the lowest VWAP of the Class B common stock during the Pricing Period. Each issuance and sale by the Company
to the Investor under the Purchase Agreement is subject to a maximum amount equal to 100% of the daily trading volume of the Class B
common stock, as reported by Bloomberg L.P., during the five trading days immediately preceding an Advance notice.
With
respect to each Advance, the Company has the option to notify the Investor of a minimum acceptable price by specifying the amount within
an Advance notice. During any trading day within a Pricing Period, two conditions will trigger an automatic reduction to the amount
of the Advance by one-third: either (i) the VWAP of the Class B common stock is below the MAP specified in the Advance notice,
or (ii) there is no VWAP available. On each Excluded Day, an automatic one-third reduction is applied to the specified Advance amount
in the Advance notice and that day will be excluded from the Pricing Period.
Each
Advance is subject to certain limitations, including that the Investor cannot purchase any shares that would result in it beneficially
owning more than 4.99% of the Company’s outstanding voting power or number of shares of Class B common stock at the time of
an Advance or acquiring in the aggregate under the Purchase Agreement more than 19.99% of the Company’s outstanding shares of Class B
common stock as of the date of the Purchase Agreement. The Exchange Cap will not apply under certain circumstances, including, where
the Company has obtained stockholder approval to issue in excess of the Exchange Cap in accordance with the rules of Nasdaq or such issuances
do not require stockholder approval under Nasdaq’s “minimum price rule.”
The
Purchase Agreement will terminate automatically on the earlier of February 16, 2026 or when the Investor has purchased an aggregate
of $50 million of Class B common stock. The Company has the right to terminate the Purchase Agreement upon five trading
days’ prior written notice to the Investor, subject to certain conditions.
In
connection with and subject to the satisfaction of certain conditions set forth in the Purchase Agreement, the Investor will pre-advance
to the Company up to $3,000,000 of the $50,000,000 commitment amount, with each Pre-Advance to be evidenced by a SEPA Note. The first
Pre-Advance, in the principal amount of $1,000,000, was advanced February 15, 2024. The second Pre-Advance, in a principal amount
of $1,000,000, was advanced on March 18, 2024. The third Pre-Advance, in the principal
amount of $1,000,000, was advanced on April 15, 2024. Each SEPA Note is subject to a 4% discount on the principal amount of such
SEPA Note. Repayment of the SEPA Notes commenced on May 15, 2024, with subsequent payments made monthly. As of June 30, 2024, the outstanding
balance on the Notes was $2,333,000. The SEPA Notes were fully repaid in July 2024.
Each
SEPA Note will accrue interest on the outstanding principal balance at the rate of 8% per annum and has a maturity date of February 15,
2025 (as may be extended at the option of the Investor). Beginning in May 2024, the Company was
required to pay, on a monthly basis, one-nineth of the outstanding principal amount of each SEPA Note, together with accrued and
unpaid interest, either (i) in cash or (ii) by submitting an Advance notice pursuant to the Purchase Agreement and selling
the Investor shares, or any combination of (i) or (ii) as determined by the Company. The initial repayment was due 90 days
after the issuance of the first SEPA Note, followed by subsequent payments due every 30 days after the previous payment. Unless
otherwise agreed to by the Investor, any funds received by the Company pursuant to the Purchase Agreement for the sale of shares will
first be used to satisfy any payments due under an outstanding SEPA Note.
At
the election of the Investor, all or a portion of the principal, interest, or other amounts outstanding under each SEPA
Note may be converted into Conversion Shares, equal to: (x) the Conversion Amount, divided by (y)
the Conversion Price. “Conversion Price” is defined as (i) $6.00 per share of Class B common stock, provided however,
on May 28, 2024, the Conversion Price shall be adjusted (downwards only) to equal the average of the daily VWAPs for the 5 consecutive
trading days immediately prior to the Reset Date, if such price is lower than the Conversion Price then in effect. The Conversion Shares
are entitled to the registration rights set forth in the Purchase Agreement.
On
March 14, 2024, the Company and the Investor entered into the Letter Agreement to amend the terms of each SEPA
Note as follows: (i) the Company may redeem early a portion or all amounts (including principal
and accrued and unpaid interest) outstanding under the SEPA Note with at least 10 trading
days’ prior written notice by the Company to the Investor. The outstanding principal balance being redeemed by the Company shall
be subject to a 10% cash redemption premium. After receipt of the Redemption Notice, the Investor shall have 10 trading days to
elect to convert all or any portion of the SEPA Note; and (ii) the Conversion Price shall
not be lower than $1.50 per share of Class B common stock.
The
Company paid a subsidiary of the Investor a structuring fee in the amount of $25,000 and in April 2024, issued to the Investor 259,350
Commitment Shares as a commitment fee. The Company and the Investor made certain representations and warranties to each other that are
customary for transactions similar to this one, subject to specified exceptions and qualifications. Each of the Company and the Investor
also agreed to indemnify the other.
As
of August 12, 2024, we had issued 9,035,561 shares under the Purchase Agreement and the SEPA Notes (including 259,350 Commitment Shares).
The
foregoing descriptions of the Purchase Agreement and the SEPA Notes and the transactions contemplated thereby are qualified in their
entirety by reference to the full text of the Purchase Agreement and the SEPA Notes, a copy or a form of which are attached hereto as
Exhibits 10.13 and 10.14, respectively, each of which is incorporated herein in its entirety by reference.
Preferred
Stock
Pursuant
to our Second Amended and Restated Articles of Incorporation, our board of directors may by resolution authorize the issuance of shares
of preferred stock from time to time in one or more series. We may reissue shares of preferred stock that are redeemed, purchased, or
otherwise acquired by us unless otherwise provided by law. Our board of directors is authorized to fix or alter the designations, powers
and preferences, and relative, participating, optional or otherwise rights if any, and qualifications, limitations or restrictions thereof,
including, without limitation, dividend rights (and whether dividends are cumulative), conversion rights, if any, voting rights (including
the number of votes if any, per share, as well as the number of members, if any, of the board of directors or the percentage of members,
if any, of the board of directors each class or series of preferred stock may be entitled to elect), rights and terms of redemption (including,
sinking fund provisions, if any), redemption price and liquidation preferences of any wholly unissued series of preferred stock, and
the number of shares constituting any such series and the designation thereof, and to increase or decrease the number of shares of any
such series subsequent to the issuance of shares of such series, but not below the number of shares of such series then issued.
Anti-takeover Effects
of Nevada Law and Our Second Amended and Restated Articles of Incorporation and Amended and Restated Bylaws
Special
Stockholder Meetings
Our
Amended and Restated Bylaws provide that special meetings of our stockholders may be called at any time by a resolution adopted by any
three or more directors, and may not be called by any other person or persons. Our Amended and Restated Bylaws prohibit the conduct of
any business at a special meeting other than as specified in the notice for such meeting.
Requirements
for Advance Notification of Director Nominations and Stockholder Proposals
Our
Amended and Restated Bylaws establish advance notice procedures with respect to stockholder proposals and the nomination of candidates
for election as directors. In order for any matter to be properly brought before a meeting of our stockholders, the stockholder submitting
the proposal or nomination will have to comply with advance notice requirements and provide us with certain information.
For
business to be properly brought before an annual meeting, the proposing stockholder must have given written notice of the nomination
or proposal, either by personal delivery or by United States mail to the Secretary not later than the close of business on the ninetieth
(90th) day nor earlier than the close of business on the one hundred twentieth (120th) day prior to the first anniversary
date of the preceding year’s annual meeting. If the date of the annual meeting is advanced more than thirty (30) days prior to
such anniversary date or delayed more than seventy (70) days after such anniversary date then to be timely such notice must be so delivered,
or mailed and received, not later than the ninetieth (90th) day prior to such annual meeting or, if later, the tenth (10th)
day following the day on which public announcement of the date of such annual meeting was first made. In no event will an adjournment
or postponement of an annual meeting of stockholders begin a new time period for giving a proposing stockholder’s notice as provided
above.
For
business to be properly brought before a special meeting of stockholders, the notice of the meeting must set forth the nature of the
business to be considered. A person or persons who have properly made a written request for a special meeting may provide the information
required for notice of a stockholder proposal simultaneously with the written request for the meeting submitted to the Secretary or within
ten calendar days after delivery of the written request for the meeting to the Secretary.
Our
Amended and Restated Bylaws also specify requirements as to the form and content of the stockholder’s notice and allow the chairman
of the meeting to prescribe rules and regulations for the conduct of stockholders’ meetings, which may preclude the conduct of
certain business at a meeting if the rules and regulations are not followed.
Authorized
but Unissued Capital Stock
Neither
Nevada law nor our governing documents require stockholder approval for any issuance of authorized shares, except as provided in NRS
78.2055 with respect to a decrease in the number of issued and outstanding shares of a class or series without a corresponding decrease
in the authorized shares. Our authorized but unissued common stock are therefore available for future issuances without stockholder approval
and could be utilized for a variety of corporate purposes, including future offerings to raise additional capital, acquisitions and employee
benefit plans. The existence of authorized but unissued and unreserved common stock could render more difficult or discourage an attempt
to obtain control of us by means of a proxy contest, tender offer, merger or otherwise.
Board
of Directors
Our
Amended and Restated Bylaws provides that the number of directors will be fixed by the board of directors.
Nevada Anti-Takeover Provisions
Nevada
law, NRS Sections 78.411 through 78.444, regulate business combinations with interested stockholders. Nevada law defines an interested
stockholder as a beneficial owner (directly or indirectly) of 10% or more of the voting power of the outstanding shares of the corporation.
Pursuant to Sections NRS 78.411 through 78.444, combinations with an interested stockholder remain prohibited for three years after
the person became an interested stockholder unless (i) the transaction is approved by the board of directors or the holders of a
majority of the outstanding shares not beneficially owned by the interested party, or (ii) the interested stockholder satisfies
certain fair value requirements. NRS 78.434 permits a Nevada corporation to opt-out of the statute with appropriate provisions in
its articles of incorporation.
NRS
Sections 78.378 through 78.3793 regulates the acquisition of a controlling interest in an issuing corporation. An issuing corporation
is defined as a Nevada corporation with 200 or more stockholders of record, of which at least 100 stockholders have addresses of record
in Nevada and does business in Nevada directly or through an affiliated corporation. NRS Section 78.379 provides that an acquiring
person and those acting in association with an acquiring person obtain only such voting rights in the control shares as are conferred
by a resolution of the stockholders of the corporation, approved at a special or annual meeting of the stockholders. Stockholders who
vote against the voting rights have dissenters’ rights in the event that the stockholders approve voting rights. NRS Section 378
provides that a Nevada corporation’s articles of incorporation or bylaws may provide that these sections do not apply to the corporation.
We have not opted out of these sections in our Second Amended and Restated Articles of Incorporation and Amended and Restated Bylaws.
Removal
of Directors; Vacancies
Under
NRS 78.335, one or more of the incumbent directors may be removed from office by the vote of stockholders representing two-thirds or
more of the voting power of the issued and outstanding stock entitled to vote. Our Amended and Restated Bylaws provide that any newly
created position on the board of directors that results from an increase in the total number of directors and any vacancies on the board
of directors will be filled only by the affirmative vote of a majority of the remaining directors, even if less than a quorum.
No
Cumulative Voting
The
NRS does not permit stockholders to cumulate their votes other than in the election of directors, and then only if expressly authorized
by the corporation’s articles of incorporation. Our Second Amended and Restated Articles of Incorporation does not expressly authorize
cumulative voting.
The
combination of these provisions will make it more difficult for our existing stockholders to replace our board of directors as well as
for another party to obtain control of us by replacing our board of directors. Because our board of directors has the power to retain
and discharge our officers, these provisions could also make it more difficult for existing stockholders or another party to effect a
change in management. In addition, the authorization of undesignated preferred stock makes it possible for our board of directors to
issue preferred stock with voting or other rights or preferences that could impede the success of any attempt to change our control.
These
provisions are intended to enhance the likelihood of continued stability in the composition of our board of directors and its policies
and to discourage coercive takeover practices and inadequate takeover bids. These provisions are also designed to reduce our vulnerability
to hostile takeovers and to discourage certain tactics that may be used in proxy fights. However, such provisions could have the effect
of discouraging others from making tender offers for our shares and may have the effect of delaying changes in our control or management.
As a consequence, these provisions may also inhibit fluctuations in the market price of our stock that could result from actual or rumored
takeover attempts. We believe that the benefits of these provisions, including increased protection of our potential ability to negotiate
with the proponent of an unfriendly or unsolicited proposal to acquire or restructure our company, outweigh the disadvantages of discouraging
takeover proposals, because negotiation of takeover proposals could result in an improvement of their terms.
Second
Amended and Restated Articles of Incorporation and Bylaw Provisions
Our
purpose is to engage in any lawful act or activity for which corporations may now or hereafter be organized under NRS Section 78
other than the business of a trust company, savings and loan association, thrift company or corporation organized for the purpose of
conducting a banking business.
Annual
Stockholder Meetings
Our
Amended and Restated Bylaws provide that annual stockholder meetings, for the purpose of electing directors and transacting any other
business as may be brought before the meeting, shall be held at a date and time fixed by the board of directors and designated in the
notice of the meeting. Failure to hold the annual meeting of stockholders at the designated time shall not affect the validity of any
action taken by the Company.
Stockholders
may participate in meetings by remote communication if the Company implements reasonable measures to verify the identity of each stockholder
participating by remote communication and to provide the stockholders a reasonable opportunity to participate and vote, including an
opportunity to communicate and read or hear the proceedings in a substantially concurrent manner with the proceedings.
Stockholder
Action by Written Consent
Any
action required or permitted by the NRS to be taken at a meeting of stockholders may be taken without a meeting if, before or after the
action, a written consent to the action is signed by stockholders holding a majority of the voting power of the Company or, if different,
the proportion of voting power required to take the action at a meeting of stockholders.
Transfer
Agent
The
transfer agent for our Class B common stock is Continental Stock Transfer & Trust Co.
Limitation
of Liability and Indemnification Matters
Under
our Second Amended and Restated Articles of Incorporation, the liability of the directors of the Company for monetary damages are eliminated
to the fullest extent permissible under Nevada law. The Company is authorized to provide indemnification to any person through bylaw
provisions, agreements with agents, vote of stockholders or disinterested directors or otherwise, subject only to the applicable limits
set forth in NRS 78.7502. Our Amended and Restated Bylaws provide that we will indemnify our directors, officers, employees, and agents
to the fullest extent permitted under the NRS.
Listing
on the Nasdaq
Our
Class B common stock is listed on the Nasdaq under the symbol “RR.”
DESCRIPTION
OF SECURITIES WE ARE OFFERING
We
are offering (i) 13,242,963 shares of our Class B common stock, (ii) Pre-Funded Warrants to purchase up to 2,312,594 shares of our Class
B common stock, and (iii) Warrants to purchase up to an aggregate of 15,555,557 shares of our Class B common stock. Each share of Class
B common stock or Pre-Funded Warrant is being sold together with a Warrant to purchase one share of Class B common stock. The shares
of Class B common stock or Pre-Funded Warrants and accompanying Warrant will be issued separately. We are also registering the shares
of Class B common stock issuable from time to time upon exercise of the Pre-Funded Warrants and Warrants offered hereby.
Class
B Common Stock
The
material terms and provisions of our Class B common stock are described under the caption “Description of Capital Stock”
in this prospectus and are incorporated herein by reference.
Warrants
to be Issued in this Offering
The material terms and provisions
of the Warrants are summarized below. This summary of some provisions of the Warrants is not complete and is qualified in its entirety
by the form of Warrants, which is filed as an exhibit to the registration statement of which this prospectus is a part. Prospective investors
should carefully review the terms and provisions of the form of Warrant for a complete description of the terms and conditions of the
Warrant.
Duration, Exercise Price
and Form. Each Warrant offered hereby will have an exercise price equal to $1.35 per share. The Warrants will be immediately
exercisable upon issuance and may be exercised until the five (5) year anniversary of the original issuance date. The exercise price
and number of shares of Class B common stock issuable upon exercise is subject to appropriate adjustment in the event of stock dividends,
stock splits, reorganizations or similar events affecting our Class B common stock. The Warrants will be issued separately from the Class
B common stock or the Pre-Funded Warrants, as the case may be, and may be transferred separately immediately thereafter. The Warrants
will be issued in certificated form only.
No
Fractional Shares. No fractional shares of Class B common stock will be issued upon the exercise of Warrants. Rather, the number
of shares of Class B common stock to be issued will, at our election, either be rounded up to the nearest whole number or we will pay
a cash adjustment in respect of such final fraction in an amount equal to such fraction multiplied by the exercise price.
Exercise
Limitation. The Warrants will be exercisable, at the option of each holder, in whole or in part, by delivering to us a duly executed
exercise notice accompanied by payment in full for the number of shares of our Class B common stock purchased upon such exercise (except
in the case of a cashless exercise as discussed below). A holder (together with its affiliates) may not exercise any portion of such
holder’s Warrants to the extent that the holder would own more than 4.99% of the outstanding Class B common stock (or at the election
of a holder prior to the date of issuance, 9.99%) immediately after exercise, except that upon at least 61 days’ prior notice from
the holder to us, the holder may increase the amount of ownership of outstanding stock after exercising the holder’s Warrants up
to 9.99% of the number of shares of our Class B common stock outstanding immediately after giving effect to the exercise, as such percentage
ownership is determined in accordance with the terms of the Warrants.
Cashless
Exercise. If at the time of exercise there is no effective registration statement registering, or the prospectus contained therein
is not available for the issuance of the underlying shares to the holder, in lieu of making the cash payment otherwise contemplated to
be made to us upon such exercise in payment of the aggregate exercise price, the holder may elect instead to receive upon such exercise
(either in whole or in part) the net number of shares of Class B common stock determined according to a formula set forth in the Warrants.
Fundamental
Transactions. In the event of a fundamental transaction, as described in the Warrants and generally including any reorganization,
recapitalization or reclassification of our Class B common stock, the sale, transfer or other disposition of all or substantially all
of our properties or assets, our consolidation or merger with or into another person, the acquisition of 50% or more of our outstanding
Class B common stock, or any person or group becoming the beneficial owner of 50% or more of the voting power represented by our outstanding
Class B common stock, the holders of the Warrants will be entitled to receive upon exercise of the Warrants the kind and amount of securities,
cash or other property that the holders would have received had they exercised the Warrants immediately prior to such fundamental transaction.
In addition, in certain circumstances, upon a fundamental transaction, the holder of a Warrant will have the right to require us to repurchase
its Warrants at the Black-Scholes value; provided, however, that, if the fundamental transaction is not within our control, including
not approved by our Board, then the holder will only be entitled to receive the same type or form of consideration (and in the same proportion),
at the Black-Scholes value of the unexercised portion of the Warrant that is being offered and paid to the holders of our Class B common
stock in connection with the fundamental transaction.
Transferability.
Subject to applicable laws, a Warrant may be transferred at the option of the holder upon surrender of the Warrants to us together
with the appropriate instruments of transfer.
Rights
as a Stockholder. Except as otherwise provided in the Warrants or by virtue of the holders’ ownership of shares of Class B
common stock, the holders of the Warrants do not have the rights or privileges of holders of our shares of Class B common stock, including
any voting rights, until such Warrant holders exercise their Warrants.
Waivers
and Amendments. The Warrants may be modified or amended, or the provisions thereof waived with the written consent of the Company
and the respective holder.
Trading
Market and Listing. There is no established trading market for the Warrants, and we do not expect a market to develop. We do not
intend to apply for a listing of the Warrants on any securities exchange or other nationally recognized trading system. Without an active
trading market, the liquidity of the Warrants will be limited. The Class B common stock issuable upon exercise of the Warrants is currently
listed on The Nasdaq Capital Market.
Pre-Funded
Warrants to be Issued in this Offering
The following summary of certain
terms and provisions of the Pre-Funded Warrants that are being offered hereby is not complete and is subject to, and qualified in its
entirety by, the provisions of the Pre-Funded Warrants, the form of which is filed as an exhibit to the registration statement of which
this prospectus forms a part. Prospective investors should carefully review the terms and provisions of the form of Pre-Funded Warrants
for a complete description of the terms and conditions of the Pre-Funded Warrants.
Duration,
Exercise Price and Form. The Pre-Funded Warrants offered hereby will have an exercise price of $0.00001 per share. The Pre-Funded
Warrants will be immediately exercisable upon issuance and may be exercised at any time after their original issuance until such Pre-Funded
Warrants are exercised in full. The exercise price and number of shares of Class B common stock issuable upon exercise are subject to
appropriate adjustment in the event of stock dividends, stock splits, reorganizations or similar events affecting our shares of Class
B common stock. The Pre-Funded Warrants and the Warrants are immediately separable and will be issued separately in this offering, but
must be purchased together in this offering. The Pre-Funded Warrants will be issued in certificated form only.
Exercisability.
The Pre-Funded Warrants will be exercisable, at the option of each holder, in whole or in part, by delivering to us a duly executed exercise
notice accompanied by payment in full for the number of shares of our Class B common stock purchased upon such exercise (except in the
case of a cashless exercise as discussed below). A holder (together with its affiliates) may not exercise any portion of the Pre-Funded
Warrants to the extent that the holder would own more than 4.99% (or at the election of a holder prior to the date of issuance, 9.99%)
of the outstanding Class B common stock immediately after exercise; provided, however, that upon 61 days’ notice to us, the holder
may increase or decrease such beneficial ownership limitation, provided that in no event shall the beneficial ownership limitation exceed
9.99% and any increase in the beneficial ownership limitation will not be effective until 61 days following notice of such increase from
the holder to us.
Cashless
Exercise. At the time a holder exercises its Pre-Funded Warrants, in lieu of making the cash payment otherwise contemplated to be
made to us upon such exercise in payment of the aggregate exercise price, the holder may elect instead to receive upon such exercise
(either in whole or in part) the net number of shares of Class B common stock determined according to a formula set forth in the Pre-Funded
Warrants.
Fundamental
Transactions. In the event of a fundamental transaction, as described in the Pre-Funded Warrants and generally including any reorganization,
recapitalization or reclassification of our Class B common stock, the sale, transfer or other disposition of all or substantially all
of our properties or assets, our consolidation or merger with or into another person, the acquisition of 50% or more of our outstanding
Class B common stock, or any person or group becoming the beneficial owner of 50% or more of the voting power represented by our outstanding
Class B common stock, the holders of the Pre-Funded Warrants will be entitled to receive upon exercise of the Pre-Funded Warrants the
kind and amount of securities, cash or other property that the holders would have received had they exercised the Pre-Funded Warrants
immediately prior to such fundamental transaction.
Transferability.
Subject to applicable laws, a Pre-Funded Warrant may be transferred at the option of the holder upon surrender of the Pre-Funded Warrants
to us together with the appropriate instruments of transfer.
Fractional
Shares. No fractional shares of Class B common stock will be issued upon the exercise of the Pre-Funded Warrants. Rather, the number
of shares of Class B common stock to be issued will, at our election, either be rounded up to the nearest whole number or we will pay
a cash adjustment in respect of such final fraction in an amount equal to such fraction multiplied by the exercise price.
Trading
Market. There is no established trading market for the Pre-Funded Warrants, and we do not expect a market to develop. We do not intend
to apply for a listing of the Pre-Funded Warrants on any securities exchange or other nationally recognized trading system. Without an
active trading market, the liquidity of the Pre-Funded Warrants will be limited. The Class B common stock issuable upon exercise of the
Pre-Funded Warrants is currently listed on The Nasdaq Capital Market.
Rights
as a Stockholder. Except as otherwise provided in the Pre-Funded Warrants or by virtue of the holders’ ownership of shares
of Class B common stock, the holders of Pre-Funded Warrants do not have the rights or privileges of holders of our shares of Class B
common stock, including any voting rights, until such Pre-Funded Warrant holders exercise their Pre-Funded Warrants.
Waivers
and Amendments. The Pre-Funded Warrants may be modified or amended, or the provisions thereof waived with the written consent of
the Company and the respective holder.
Placement
Agent Warrants
We have also agreed to issue
to the Placement Agent, or its designees, as compensation in connection with this offering, warrants to purchase up to 1,088,889 shares
of Class B common stock (the “Placement Agent Warrants”). The Placement Agent Warrants will be exercisable immediately and
will have substantially the same terms as the Warrants described above, except that the Placement Agent Warrants will have an exercise
price of $1.6875 per share (representing 125% of the combined public offering price per share and accompanying Warrant) and a termination
date that will be five (5) years from the commencement of the sales pursuant to this offering. See “Plan of Distribution”
below.
MATERIAL
U.S. FEDERAL INCOME TAX CONSEQUENCES
The
following is a summary of the material U.S. federal income tax considerations arising from and relating to the acquisition, ownership
and disposition of the common shares acquired pursuant to this prospectus, the exercise, disposition, and lapse of Warrants acquired
pursuant to this prospectus (the “Public Warrants”), and the acquisition, ownership, and disposition of common shares received
upon exercise of the Public Warrants (the “Warrant Shares”), the ownership, exercise and disposition of Pre-Funded Warrants
acquired pursuant to this prospectus and the common shares received upon the exercise of the Pre-Funded Warrants. The common shares,
Public Warrants, Warrant Shares and Pre-Funded Warrants may be referred to in this summary as the “securities.”
This
discussion is limited to certain U.S. federal income tax considerations to beneficial owners of our securities who are initial purchasers
of our common shares and Warrants pursuant to this offering and hold our securities as capital assets within the meaning of Section 1221(a)
of the U.S. Internal Revenue Code of 1986, as amended (the “Code”) (generally, property held for investment). This discussion
assumes that the common shares and warrants will trade separately and that any distributions made (or deemed made) by us on the common
shares and any consideration received (or deemed received) by a holder in consideration for the sale or other disposition of our securities
will be in U.S. dollars. This discussion is a summary only and does not consider all aspects of U.S. federal income taxation that may
be relevant to the acquisition, ownership and disposition of our securities by a prospective investor in light of its particular circumstances
or that is subject to special rules under the U.S. federal income tax laws, including, but not limited to:
| ● | banks
and other financial institutions or financial services entities; |
| ● | retirement
plans, individual retirement accounts or other tax-deferred accounts; |
| ● | taxpayers
that are subject to the mark-to-market tax accounting rules; |
| ● | S-corporations,
partnerships or other flow-through entities and investors therein; |
| ● | governments
or agencies or instrumentalities thereof; |
| ● | regulated
investment companies; |
| ● | real
estate investment trusts; |
| ● | passive
foreign investment companies; |
| ● | controlled
foreign corporations; |
| ● | qualified
foreign pension funds; |
| ● | expatriates
or former long-term residents of the United States; |
| ● | persons
that actually or constructively own five percent or more of our voting shares; |
| ● | persons
that acquired our securities pursuant to an exercise of employee share options, in connection
with employee share incentive plans or otherwise as compensation or in connection with services; |
| ● | persons
required for U.S. federal income tax purposes to conform the timing of income accruals to
their financial statements under Section 451 of the Code; |
| ● | persons
subject to the alternative minimum tax; |
| ● | persons
that hold our securities as part of a straddle, constructive sale, hedging, conversion or
other integrated or similar transaction; or |
| ● | U.S.
Holders (as defined below) whose functional currency is not the U.S. dollar. |
The
discussion below is based upon current provisions of the Code, applicable U.S. Treasury regulations promulgated under the Code (“Treasury
Regulations”), judicial decisions and administrative rulings of the Internal Revenue Service (“IRS”), all as in effect
on the date hereof, and all of which are subject to differing interpretations or change, possibly on a retroactive basis. Any such differing
interpretations or change could alter the U.S. federal income tax consequences discussed below. Furthermore, this discussion does not
address any aspect of U.S. federal non-income tax laws, such as gift, estate or Medicare contribution tax laws, or state, local or non-U.S.
tax laws.
We
have not sought, and will not seek, a ruling from the IRS as to any U.S. federal income tax consequence described herein. The IRS may
disagree with the discussion herein, and its determination may be upheld by a court. Moreover, there can be no assurance that future
legislation, regulations, administrative rulings or court decisions will not adversely affect the accuracy of the statements in this
discussion.
As
used herein, the term “U.S. Holder” means a beneficial owner of our securities that is for U.S. federal income tax purposes:
(i) an individual who is a citizen or resident of the United States, (ii) a corporation (or other entity treated as a
corporation for U.S. federal income tax purposes) that is created or organized (or treated as created or organized) in or under the laws
of the United States, any state thereof or the District of Columbia, (iii) an estate the income of which is subject to U.S.
federal income taxation regardless of its source or (iv) a trust if (A) a court within the United States is able to exercise
primary supervision over the administration of the trust and one or more United States persons have the authority to control all
substantial decisions of the trust, or (B) it has in effect a valid election under Treasury Regulations to be treated as a United States
person.
This
discussion does not consider the tax treatment of partnerships or other pass-through entities (including branches) or persons who hold
our securities through such entities. If a partnership (or other entity or arrangement classified as a partnership for U.S. federal income
tax purposes) is the beneficial owner of our securities, the U.S. federal income tax treatment of a partner in the partnership generally
will depend on the status of the partner and the activities of the partner and the partnership. If you are a partner or a partnership
holding our securities, we urge you to consult your own tax advisor.
THIS
DISCUSSION IS ONLY A SUMMARY OF CERTAIN U.S. FEDERAL INCOME TAX CONSIDERATIONS ASSOCIATED WITH THE ACQUISITION, OWNERSHIP AND DISPOSITION
OF OUR SECURITIES. EACH PROSPECTIVE INVESTOR IN OUR SECURITIES IS URGED TO CONSULT ITS OWN TAX ADVISOR WITH RESPECT TO THE PARTICULAR
TAX CONSEQUENCES TO SUCH INVESTOR OF THE ACQUISITION, OWNERSHIP AND DISPOSITION OF OUR SECURITIES, INCLUDING THE APPLICABILITY AND EFFECT
OF ANY STATE, LOCAL, AND NON-UNITED STATES TAX LAWS.
Treatment
of Pre-Funded Warrants
Although
it is not entirely free from doubt, applicable authority indicates that, and we intend to take the position that, the Pre-Funded Warrants
should be treated as a separate class of our common shares for U.S. federal income tax purposes and a U.S. Holder of Pre-Funded Warrants
should generally be taxed in the same manner as a holder of common shares except as described below. Accordingly, no gain or loss should
be recognized upon the exercise of a Pre-Funded Warrant and, upon exercise, the holding period of the common shares received upon exercise
of the Pre-Funded Warrant should include the holding period of the a Pre-Funded Aarrant. The tax basis of the Pre-Funded Warrant should
carry over to the common shares received upon exercise, increased by the exercise price of $0.00001 per share. However, such characterization
is not binding on the IRS, and the IRS may treat the Pre-Funded Warrants as warrants to acquire common shares. If so, the amount and
character of a U.S. Holder’s gain with respect to an investment in Pre-Funded Warrants could change. Accordingly, each U.S. Holder
should consult its own tax advisor regarding the risks associated with the acquisition of a Pre-Funded Warrant pursuant to this prospectus
(including potential alternative characterizations). The balance of this discussion generally assumes that the characterization described
above is respected for U.S. federal income tax purposes.
U.S.
Federal Income Tax Consequences of the Acquisition of a Combination of Common Share or Pre-Funded Warrant and Public Warrant
The
purchase price for each combination of a common share and a Public Warrant will be allocated between these two components in proportion
to their relative fair market values at the time such securities are purchased by the U.S. Holder. This allocation of the purchase price
for each such combination will establish a U.S. Holder’s initial tax basis for U.S. federal income tax purposes in the common share
and a Public Warrant that comprise each such combination. For U.S. federal income tax purposes, each holder of our commons shares and
Public Warrants must allocate the purchase price paid by such holder for such securities between the one of our common shares and the
one Public Warrant based on the relative fair market value of each at the time of issuance. Under U.S. federal income tax law, each investor
must make its own determination of such value based on all the relevant facts and circumstances. The price allocated to each common share
and one Public Warrant should constitute the holder’s initial tax basis in such share and Public Warrant, respectively.
The
purchase price for each combination of a Pre-Funded Warrant and a Public Warrant will be allocated between these two components in proportion
to their relative fair market values at the time such securities are purchased by the U.S. Holder. For U.S. federal income tax purposes,
each holder of our Pre-Funded Warrants and Public Warrants must allocate the purchase price paid by such holder for such securities between
the one of our Pre-Funded Warrants and the one Public Warrant based on the relative fair market value of each at the time of issuance.
Under U.S. federal income tax law, each investor must make its own determination of such value based on all the relevant facts and circumstances.
The price allocated to each Pre-Funded Warrant and one Public Warrant should constitute the holder’s initial tax basis in such
Pre-Funded Warrant and Public Warrant, respectively.
The
foregoing treatment of our common shares, Pre-Funded Warrants and Public Warrants and a holder’s purchase price allocation are
not binding on the IRS or the courts. No assurance can be given that the IRS or the courts will agree with the characterization described
above or the discussion below. Accordingly, each prospective investor is urged to consult its tax advisor regarding the tax consequences
of an investment in our securities. The balance of this discussion assumes that the characterization of the securities described
above is respected for U.S. federal income tax purposes.
U.S.
Holders
Taxation
of Distributions
If
we pay distributions in cash or other property (other than certain distributions of our stock or rights to acquire our stock) to U.S.
Holders of our common shares, such distributions will constitute dividends for U.S. federal income tax purposes to the extent paid from
our current or accumulated earnings and profits, as determined under U.S. federal income tax principles. Distributions in excess of current
and accumulated earnings and profits will constitute a return of capital that will be applied against and reduce (but not below zero)
the U.S. Holder’s adjusted tax basis in our common shares. Any remaining excess will be treated as gain realized on the sale or
other disposition of the shares of our common shares and will be treated as described under “U.S. Holders — Gain or Loss
on Sale, Taxable Exchange or Other Taxable Disposition of Our Common Shares, Pre-Funded Warrants and Public Warrants” below.
Dividends
we pay to a corporate U.S. Holder generally will qualify for the dividends received deduction if certain holding period requirements
are met. With certain exceptions, and provided certain holding period requirements are met, dividends we pay to a non-corporate U.S.
Holder will generally be taxed as qualified dividend income at the preferential tax rate for long-term capital gains.
Gain
or Loss on Sale, Taxable Exchange or Other Taxable Disposition of Our Common Shares, Pre-Funded Warrants and Public Warrants
A
U.S. Holder generally will recognize capital gain or loss on a sale or other taxable disposition of our common shares, Pre-Funded Warrants
or Public Warrants. Any such capital gain or loss generally will be long-term capital gain or loss if the U.S. Holder’s holding
period for such common shares, Pre-Funded Warrants or Public Warrants exceeds one year. Long-term capital gains recognized by a non-corporate
U.S. holder are currently eligible to be taxed preferential rates. The deductibility of capital losses is subject to limitations.
The
amount of gain or loss recognized on a sale or other taxable disposition generally will be equal to the difference between (i) the
sum of the amount of cash and the fair market value of any property received in such disposition and (ii) the U.S. Holder’s
adjusted tax basis in our common shares or warrants so disposed of. A U.S. Holder’s adjusted tax basis in our common shares and
warrants generally will equal the U.S. Holder’s acquisition cost reduced, in the case of our common shares, by any prior distributions
treated as a return of capital. See “U.S. Holders—Exercise, Lapse or Redemption of a Warrant” below for a discussion
regarding a U.S. Holder’s tax basis in a common shares acquired pursuant to the exercise of a warrant.
Exercise
or Lapse of a Public Warrant
Except
as discussed below with respect to the cashless exercise of a warrant, a U.S. Holder generally will not recognize gain or loss upon the
acquisition of a common share on the exercise of a warrant for cash. A U.S. Holder’s initial tax basis in a common share received
upon exercise of the warrant generally will equal the sum of the U.S. Holder’s initial investment in the warrant (that is, the
portion of the U.S. Holder’s purchase price that is allocated to the warrant, as described above under “—U.S. Federal
Income Tax Consequences of the Acquisition of a Combination of Common Share or Pre-Funded Warrant and Public Warrant”) and the
exercise price of such warrant. It is unclear whether a U.S. Holder’s holding period for a warrant share received upon exercise
of the warrants will commence on the date of exercise of the warrant or the day following the date of exercise of the warrant; in either
case, the holding period will not include the period during which the U.S. Holder held the warrant. If a warrant is allowed to lapse
unexercised, a U.S. Holder generally will recognize a capital loss equal to such holder’s tax basis in the warrant.
The
tax consequences of a cashless exercise of a warrant are not clear under current law. A cashless exercise may not be taxable, either
because the exercise is not a realization event or because the exercise is treated as a “recapitalization” for U.S. federal
income tax purposes. In either situation, a U.S. Holder’s tax basis in our common shares received generally would equal the U.S.
Holder’s tax basis in the warrants exercised therefor. If the cashless exercise were not a realization event, it is unclear whether
a U.S. Holder’s holding period for our common shares will commence on the date of exercise of the warrant or the day following
the date of exercise of the warrant. If the cashless exercise were treated as a recapitalization, the holding period of our common shares
would include the holding period of the warrants exercised therefor.
It
is also possible that a cashless exercise could be treated in whole or in part as a taxable exchange in which gain or loss would be recognized.
In such event, a U.S. Holder could be deemed to have surrendered a number of warrants having an aggregate value (as measured by the excess
of the fair market value of our common shares over the exercise price of the warrants) equal to the exercise price for the total number
of warrants to be exercised (i.e., the warrants underlying the number of our common shares actually received by the U.S. Holder
pursuant to the cashless exercise). The U.S. Holder would recognize capital gain or loss in an amount equal to the difference between
the value of the warrants deemed surrendered and the U.S. Holder’s tax basis in such warrants. Such gain or loss would be long-term
or short-term, depending on the U.S. Holder’s holding period in the warrants deemed surrendered. In this case, a U.S. Holder’s
tax basis in our common shares received would equal the sum of the U.S. Holder’s tax basis in the warrants exercised and the exercise
price of such warrants. It is unclear whether a U.S. Holder’s holding period for the common shares would commence on the date following
the date of exercise or on the date of exercise of the warrant; in either case, the holding period would not include the period during
which the U.S. Holder held the warrant.
Alternative
characterizations are also possible (including as a taxable exchange of all of the warrants surrendered by the U.S. Holder for our common
shares received upon exercise). Due to the absence of authority on the U.S. federal income tax treatment of a cashless exercise, including
when a U.S. Holder’s holding period would commence with respect to the common shares received, there can be no assurance which,
if any, of the alternative tax consequences and holding periods described above would be adopted by the IRS or a court of law. Accordingly,
U.S. Holders should consult their tax advisors regarding the tax consequences of a cashless exercise.
Possible
Constructive Distributions
Depending
on the circumstances, certain adjustments to the warrants may be treated as constructive distributions. An adjustment which has the effect
of preventing dilution pursuant to a bona fide reasonable adjustment formula generally is not taxable. The U.S. Holders of the warrants
would, however, be treated as receiving a constructive distribution from us if, for example, the adjustment increases the warrant holders’
proportionate interest in our assets or earnings and profits (e.g., through an increase in the number of our common shares that would
be obtained upon exercise or through a decrease to the exercise price) as a result of a taxable distribution of cash or other property
to the holders of our common shares. Any such constructive distribution would generally be subject to tax as described under “U.S.
Holders—Taxation of Distributions” above in the same manner as if the U.S. Holders of the warrants received a cash distribution
from us equal to the fair market value of such increased interest resulting from the adjustment.
Non-U.S.
Holders
This
section applies to “Non-U.S. Holders.” As used herein, the term “Non-U.S. Holder” means a beneficial owner of
our common shares or warrants that is not a U.S. Holder and is not a partnership or other entity classified as a partnership for
U.S. federal income tax purposes, but such term generally does not include an individual who is present in the United States for
183 days or more in the taxable year of disposition. If you are such an individual, you should consult your tax advisor regarding
the U.S. federal income tax consequences of the acquisition, ownership or sale or other disposition of our securities.
Taxation
of Distributions
In
general, any distributions (including constructive distributions) we make to a Non-U.S. Holder of shares of our common shares, to the
extent paid out of our current or accumulated earnings and profits (as determined under U.S. federal income tax principles), will constitute
dividends for U.S. federal income tax purposes. Provided such dividends are not effectively connected with the Non-U.S. Holder’s
conduct of a trade or business within the United States, we will be required to withhold tax from the gross amount of the dividend
at a rate of 30%, unless such Non-U.S. Holder is eligible for a reduced rate of withholding tax under an applicable income tax treaty
and provides proper certification of its eligibility for such reduced rate (usually on an IRS Form W-8BEN or W-8BEN-E, as applicable).
In the case of any constructive dividend, it is possible that this tax would be withheld from any amount owed to a Non-U.S. Holder by
the applicable withholding agent, including cash distributions on other property or sale proceeds from warrants or other property subsequently
paid or credited to such holder. Any distribution not constituting a dividend will be treated first as reducing (but not below zero)
the Non-U.S. Holder’s adjusted tax basis in our common shares and, to the extent such distribution exceeds the Non-U.S. Holder’s
adjusted tax basis, as gain realized from the sale or other disposition of our common shares, which will be treated as described under
“Non-U.S. Holders — Gain on Sale, Taxable Exchange or Other Taxable Disposition of Our Class A Common Stock and Warrants”
below. In addition, if we determine that we are or are likely to be classified as a “United States real property holding corporation”
(see “Non-U.S. Holders — Gain on Sale, Taxable Exchange or Other Taxable Disposition of Our Class A Common Stock and
Warrants” below), we will withhold 15% of any distribution that exceeds our current and accumulated earnings and profits, including
a distribution in redemption of our common shares. See also “Non-U.S. Holders — Possible Constructive Distributions”
for potential U.S. federal tax consequences with respect to constructive distributions.
Dividends
that we pay to a Non-U.S. Holder that are effectively connected with such Non-U.S. Holder’s conduct of a trade or business within
the United States will not be subject to U.S. withholding tax, provided such Non-U.S. Holder complies with certain certification
and disclosure requirements (usually by providing an IRS Form W-8ECI). Instead, the effectively connected dividends will be subject
to regular U.S. federal income tax as if the Non-U.S. Holder were a U.S. resident, unless an applicable income tax treaty provides otherwise.
A Non-U.S. Holder that is a foreign corporation receiving effectively connected dividends may also be subject to an additional “branch
profits tax” imposed at a rate of 30% (or a lower treaty rate).
Exercise,
Lapse or Redemption of a Warrant
The
U.S. federal income tax treatment of a Non-U.S. Holder’s exercise of a warrant, or the lapse of a warrant held by a Non-U.S. Holder,
generally will correspond to the U.S. federal income tax treatment of the exercise or lapse of a warrant by a U.S. Holder, as described
under “U.S. Holders — Exercise, Lapse or Redemption of a Warrant” above, although to the extent a cashless exercise
results in a taxable exchange, the consequences would be similar to those described below under “Non-U.S. Holders — Gain
on Sale, Taxable Exchange or Other Taxable Disposition of Common Shares and Warrants.” The U.S. federal income tax treatment for
a Non-U.S. Holder of a redemption of warrants for cash (or if we purchase warrants in an open market transaction) would be similar to
that described below in “Non-U.S. Holders — Gain on Sale, Taxable Exchange or Other Taxable Disposition of Our Common Shares
and Warrants.”
Gain
on Sale, Taxable Exchange or Other Taxable Disposition of Our Common Shares and Warrants
Subject
to the discussion of FATCA and backup withholding below, a Non-U.S. Holder generally will not be subject to U.S. federal income or withholding
tax in respect of gain recognized on a sale, taxable exchange or other taxable disposition of our common shares (including upon a dissolution
and liquidation if we do not complete an initial business combination within the required time period) or warrants (including an expiration
or redemption of our warrants), unless:
| ● | the
gain is effectively connected with the conduct of a trade or business by the Non-U.S. Holder
within the United States (and, under certain income tax treaties, is attributable to
a permanent establishment or fixed base maintained by the Non-U.S. Holder in the United States);
or |
| ● | we
are or have been a “United States real property holding corporation” for
U.S. federal income tax purposes at any time during the shorter of the five-year period ending
on the date of disposition or the period that the Non-U.S. Holder held our common shares,
and, in the case where shares of our common shares are regularly traded on an established
securities market, the Non-U.S. Holder has owned, directly or constructively, more than 5%
of our common shares at any time within the shorter of the five-year period preceding the
disposition or such Non-U.S. Holder’s holding period for our common shares. There can
be no assurance that our common shares will be treated as regularly traded on an established
securities market for this purpose. These rules may be modified for Non-U.S. Holders of warrants.
If we are or have been a “United States real property holding corporation”
and you own warrants, you are urged to consult your own tax advisor regarding the application
of these rules. |
Unless
an applicable treaty provides otherwise, gain described in the first bullet point above will generally be subject to tax at the applicable
U.S. federal income tax rates as if the Non-U.S. Holder were a U.S. resident. Any gains described in the first bullet point above of
a Non-U.S. Holder that is a foreign corporation may also be subject to an additional “branch profits tax” at a 30% rate (or
lower treaty rate).
If
the second bullet point above applies to a Non-U.S. Holder, gain recognized by such holder on the sale, exchange or other disposition
of our common shares or warrants will generally be subject to tax at applicable U.S. federal income tax rates as if the Non-U.S. Holder
were a U.S. resident. In addition, a buyer of our common shares or warrants from such holder may be required to withhold U.S. federal
income tax at a rate of 15% of the amount realized upon such disposition. We cannot determine whether we will be a United States
real property holding corporation in the future. In general, we would be classified as a United States real property holding corporation
if the fair market value of our “United States real property interests” equals or exceeds 50% of the sum of the fair
market value of our worldwide real property interests plus our other assets used or held for use in a trade or business, as determined
for U.S. federal income tax purposes.
Possible
Constructive Distributions
Depending
on the circumstances, certain adjustments to the warrants may be treated as constructive distributions. An adjustment which has the effect
of preventing dilution pursuant to a bona fide reasonable adjustment formula generally is not taxable. The Non-U.S. Holders of the warrants
would, however, be treated as receiving a constructive distribution from us if, for example, the adjustment increases the warrant holders’
proportionate interest in our assets or earnings and profits (e.g., through an increase in the number of shares of our common shares
that would be obtained upon exercise or through a decrease to the exercise price) as a result of a taxable distribution of cash or other
property to the holders of shares of our common shares. Any such constructive distribution would generally be taxed as described under
“Non-U.S. Holders — Taxation of Distributions” above, in the same manner as if the Non-U.S. Holders of the warrants
received a cash distribution from us equal to the fair market value of such increased interest resulting from the adjustment.
Information
Reporting and Backup Withholding
Dividend
payments (including constructive dividends) with respect to our common shares and proceeds from the sale, exchange or redemption of shares
of our common shares or warrants may be subject to information reporting to the IRS and possible United States backup withholding.
Backup withholding will not apply, however, to payments made to a U.S. Holder who furnishes a correct taxpayer identification number
and makes other required certifications, or who is otherwise exempt from backup withholding and establishes such exempt status. Payments
made to a Non-U.S. Holder generally will not be subject to backup withholding if the Non-U.S. Holder provides certification of its foreign
status, under penalties of perjury, on a duly executed applicable IRS Form W-8 or by otherwise establishing an exemption.
Backup
withholding is not an additional tax. Amounts withheld under the backup withholding rules may be credited against a holder’s U.S.
federal income tax liability, and a holder generally may obtain a refund of any excess amounts withheld by timely filing the appropriate
claim for refund with the IRS and furnishing any required information. All holders should consult their tax advisors regarding the application
of information reporting and backup withholding to them.
FATCA
Withholding Taxes
Sections 1471
through 1474 of the Code and the Treasury Regulations and administrative guidance promulgated thereunder (commonly referred to as the
“Foreign Account Tax Compliance Act” or “FATCA”) generally impose withholding of 30% in certain circumstances
on payments of dividends (including constructive dividends) and, subject to the proposed Treasury Regulations discussed below, on proceeds
from sales or other disposition of our securities paid to “foreign financial institutions” (which is broadly defined for
this purpose and includes investment vehicles) and certain other non-U.S. entities unless various U.S. information reporting and due
diligence requirements (relating to ownership by U.S. persons of interests in or accounts with those entities) have been satisfied or
an exemption applies (typically certified as to by the delivery of a properly completed IRS Form W-8BEN-E). If FATCA withholding
is imposed, a beneficial owner that is not a foreign financial institution will be entitled to a refund of any amounts withheld by filing
a U.S. federal income tax return (which may entail significant administrative burden). Foreign financial institutions located in jurisdictions
that have an intergovernmental agreement with the United States governing FATCA may be subject to different rules. Similarly, dividends
and, subject to the proposed Treasury Regulations discussed below, proceeds from sales or other disposition in respect of our securities
held by an investor that is a non-financial non-U.S. entity that does not qualify under certain exceptions generally will be subject
to withholding at a rate of 30%, unless such entity either (i) certifies to us or the applicable withholding agent that such entity
does not have any “substantial United States owners” or (ii) provides certain information regarding the entity’s
“substantial United States owners,” which will in turn be provided to the U.S. Department of the Treasury. The U.S.
Department of the Treasury has proposed regulations which eliminate the federal withholding tax of 30% applicable to the gross proceeds
of a sale or other disposition of our securities. Withholding agents may rely on the proposed Treasury Regulations until final regulations
are issued. Prospective investors should consult their tax advisors regarding the possible effects of FATCA on their investment in our
securities.
THE
U.S. FEDERAL INCOME TAX DISCUSSION SET FORTH ABOVE IS INCLUDED FOR GENERAL INFORMATION ONLY AND MAY NOT BE APPLICABLE DEPENDING UPON
A HOLDER’S PARTICULAR SITUATION. HOLDERS ARE URGED TO CONSULT THEIR OWN TAX ADVISORS WITH RESPECT TO THE TAX CONSEQUENCES TO THEM
OF THE ACQUISITION, OWNERSHIP AND DISPOSITION OF OUR SECURITIES, INCLUDING THE TAX CONSEQUENCES UNDER STATE, LOCAL, ESTATE, NON-U.S.
AND OTHER TAX LAWS AND TAX TREATIES AND THE POSSIBLE EFFECTS OF CHANGES IN U.S. OR OTHER TAX LAWS.
PLAN
OF DISTRIBUTION
Pursuant
to an engagement agreement dated August 4, 2024 (the “Engagement Agreement”), we have engaged the Placement Agent to
act as our exclusive Placement Agent to solicit offers to purchase the shares of Class B common stock, Warrants and Pre-Funded Warrants.
The Placement Agent is not purchasing or selling any such securities, nor is it required to arrange for the purchase and sale of any
specific number or dollar amount of such securities, other than to use its “reasonable best efforts” to arrange for the sale
of such securities by us. Therefore, we may not sell all of the shares of Class B common stock, the Warrants and the Pre-Funded Warrants
being offered. The terms of this offering were subject to market conditions and negotiations between us, the Placement Agent and prospective
investors. The Placement Agent will have no authority to bind us by virtue of the Engagement Agreement. This is a reasonable best efforts
offering and there is no minimum offering amount required as a condition to the closing of this offering. The Placement Agent may retain
sub-agents and selected dealers in connection with this offering.
Investors purchasing the securities offered hereby will have the option
to execute a securities purchase agreement with us. In addition to rights and remedies available to all purchasers in this offering under
federal securities and state law, the purchasers which enter into a securities purchase agreement will also be able to bring claims of
breach of contract against us. The ability to pursue a claim for breach of contract is material to larger purchasers in this offering
as a means to enforce the following covenants uniquely available to them under the securities purchase agreement: (i) a covenant to not
enter into variable rate financings for a period of one (1) year following the closing of the offering, subject to certain exceptions;
and (ii) a covenant to not enter into any equity financings for ninety (90) days from closing of the offering, subject to certain
exceptions.
The
nature of the representations, warranties and covenants in the securities purchase agreements shall include:
| ● | standard
issuer representations and warranties on matters such as organization, qualification, authorization,
no conflict, no governmental filings required, current in SEC filings, no litigation, labor
or other compliance issues, environmental, intellectual property and title matters and compliance
with various laws such as the Foreign Corrupt Practices Act; and |
| ● | covenants
regarding matters such as registration of warrant shares, no integration with other offerings,
filing of a Current Report on Form 8-K to disclose entering into the securities purchase
agreements, no stockholder rights plans, no material nonpublic information, use of proceeds,
indemnification of purchasers, reservation and listing of shares of Class B common stock,
and no subsequent equity sales for ninety (90) days. |
Delivery of the shares of the shares of Class B common stock, the Warrants
and the Pre-Funded Warrants offered hereby is expected to occur on or about September 3, 2024, subject to satisfaction of certain customary
closing conditions.
Fees
and Expenses
We have agreed to pay the Placement Agent a total cash fee equal to
7.0% of the gross proceeds raised in this offering. We will also pay the Placement Agent $80,000 for the fees and expenses of the Placement
Agent’s legal counsel and other out-of-pocket expenses and up to $15,950 for the Placement Agent’s clearing expenses.
Placement
Agent Warrants
In addition, we have agreed to issue to the Placement Agent, or its
designees, as compensation in connection with this offering, the Placement Agent Warrants to purchase up to that number of shares of our
Class B common stock equal to 7% of the aggregate number of shares of Class B common stock (including the shares of Class B common stock
issuable upon the exercise of the Pre-Funded Warrants ) issued in this offering at an exercise price of $1.6875 per share (equal to 125%
of the combined public offering price per share of Class B common stock and accompanying Warrant). The Placement Agents Warrants will
be exercisable upon issuance and will terminate on the five (5) year anniversary of commencement of sales in this offering. The Placement
Agent Warrants are registered by the registration statement of which this prospectus is a part. The form of the Placement Agent Warrants
is included as an exhibit to the registration statement of which this prospectus forms a part.
The
Placement Agent Warrants provide for customary anti-dilution provisions (for stock dividends, splits and recapitalizations and the like)
consistent with FINRA Rule 5110. Pursuant to FINRA Rule 5110(e), the Placement Agent Warrants and any shares issuable thereunder shall
not be sold, transferred, assigned, pledged, or hypothecated, or be the subject of any hedging, short sale, derivative, put or call transaction
that would result in the effective economic disposition of the securities by any person for a period of 180 days immediately following
the date of commencement of sales of this offering, except the transfer of any security: (i) by operation of law or by reason of reorganization
of the Company; (ii) to any FINRA member firm participating in the offering and the officers, partners, registered persons or affiliates
thereof, if all securities so transferred remain subject to the lock-up restriction set forth above for the remainder of the time period;
(iii) if the aggregate amount of our securities held by the Placement Agent persons does not exceed 1% of the securities being offered;
(iv) that is beneficially owned on a pro-rata basis by all equity owners of an investment fund, provided that no participating member
manages or otherwise directs investments by the fund and the participating members in the aggregate do not own more than 10% of the equity
in the fund; (v) the exercise or conversion of any security, if all securities remain subject to the lock-up restriction set forth above
for the remainder of the time period; (vi) if we meet the registration requirements of Forms S-3, F-3 or F-10; or (vii) back to us in
a transaction exempt from registration under the Securities Act.
We estimate the total expenses of this offering paid or payable by
us, exclusive of the Placement Agent’s cash fee of 7% of the gross proceeds and expenses, will be approximately $374,251. After
deducting the fees due to the Placement Agent and our estimated expenses in connection with this offering, we expect the net proceeds
from this offering will be approximately $19.1 million (based on a combined public offering price per share of Class B common stock and
accompanying Warrant of $1.35).
The
following table shows the per share and accompanying Warrant, per Pre-Funded Warrant and accompanying Warrant and total cash fees we
will pay to the Placement Agent in connection with the sale of the Class B common stock, the Warrants and the Pre-Funded Warrants pursuant
to this prospectus.
| |
Per Share and
Accompanying
Warrant | | |
Per
Pre-Funded
Warrant and
Accompanying
Warrant | | |
Total | |
Combined public offering price | |
$ | 1.3500 | | |
$ | 1.34999 | | |
$ | 20,999,978.82 | |
Placement agent fees | |
$ | 0.0945 | | |
$ | 0.09450 | | |
$ | 1,470,000.14 | |
Proceeds to us, before expenses | |
$ | 1.2555 | | |
$ | 1.25549 | | |
$ | 19,529,978.68 | |
| |
Per Share and Accompanying Warrant | | |
Per Pre-Funded Warrant and Accompanying Warrant | | |
Total | |
Combined public offering price | |
$ | 1.3500 | | |
$ | 1.34999 | | |
$ | 20,999,978.82 | |
Placement agent fees(1) | |
$ | 0.0945 | | |
$ | 0.09450 | | |
$ | 1,470,000.14 | |
Proceeds to us, before expenses(2) | |
$ | 1.2555 | | |
$ | 1.25549 | | |
$ | 19,529,978.68 | |
Indemnification
We
have agreed to indemnify the Placement Agent against certain liabilities, including liabilities under the Securities Act and liabilities
arising from breaches of representations and warranties contained in our Engagement Agreement with the Placement Agent. We have also
agreed to contribute to payments the Placement Agent may be required to make in respect of such liabilities.
In
addition, we will indemnify the purchasers of securities in this offering against liabilities arising out of or relating to (i) any breach
of any of the representations, warranties, covenants or agreements made by us in the securities purchase agreement or related documents
or (ii) any action instituted against a purchaser by a third party (other than a third party who is affiliated with such purchaser) with
respect to the securities purchase agreement or related documents and the transactions contemplated thereby, subject to certain exceptions.
Lock-up
Agreements
We have agreed to a covenant to not enter into any subsequent equity
sales for ninety (90) days. Each of our officers and directors have agreed to be subject to a lock-up period of sixty (60) days following
the date of closing of the offering pursuant to this prospectus. This means that, during the applicable lock-up period, we and such persons
may not offer for sale, contract to sell, sell, distribute, grant any option, right or warrant to purchase, pledge, hypothecate or otherwise
dispose of, directly or indirectly, any of our shares of Class B common stock or any securities convertible into, or exercisable or exchangeable
for, shares of Class B common stock, subject to customary exceptions. The Placement Agent may waive the terms of these lock-up agreements
in its sole discretion and without notice. In addition, we have agreed to not issue any securities that are subject to a price reset based
on the trading prices of our Class B common stock or upon a specified or contingent event in the future or enter into any agreement to
issue securities at a future determined price for a period of one (1) year following the closing date of this offering, subject to certain
exceptions. The Placement Agent may waive this prohibition in its sole discretion and without notice.
Tail
We
have also agreed to pay the Placement Agent a tail fee equal to the cash and warrant compensation in this offering, if any investor,
subject to certain exceptions, who was brought over-the-wall by the Placement Agent or its affiliates or had back and forth contact with
the Placement Agent or its affiliates about us during the term of its engagement, provides us with capital in any public or private offering
or other financing or capital raising transaction during the twelve (12) month period following expiration or termination of the
Engagement Agreement, subject to certain exceptions.
Other
Relationships
From
time to time, the Placement Agent may provide in the future various advisory, investment and commercial banking and other services to
us in the ordinary course of business, for which they have received and may continue to receive customary fees and commissions. However,
except as disclosed in this prospectus, we have no present arrangements with the Placement Agent for any further services.
In
addition, in the ordinary course of their business activities, the Placement Agent and its affiliates may make or hold a broad array
of investments and actively trade debt and equity securities (or related derivative securities) for their own account and for the accounts
of their customers. Such investments and securities activities may involve securities and/or instruments of ours or our affiliates. The
Placement Agent and its affiliates may also make investment recommendations and/or publish or express independent research views in respect
of such securities or financial instruments and may hold, or recommend to clients that they acquire, long and/or short positions in such
securities and instruments.
Except
as disclosed in this prospectus, we have no present arrangements with the Placement Agent for any further services.
Regulation
M Compliance
The
Placement Agent may be deemed to be an underwriter within the meaning of Section 2(a)(11) of the Securities Act, and any commissions
received by it and any profit realized on the sale of our securities offered hereby by it while acting as principal might be deemed to
be underwriting discounts or commissions under the Securities Act. The Placement Agent will be required to comply with the requirements
of the Securities Act and the Exchange Act, including, without limitation, Rule 10b-5 and Regulation M under the Exchange Act. These
rules and regulations may limit the timing of purchases and sales of our securities by the Placement Agent. Under these rules and regulations,
the Placement Agent may not (i) engage in any stabilization activity in connection with our securities; and (ii) bid for or purchase
any of our securities or attempt to induce any person to purchase any of our securities, other than as permitted under the Exchange Act,
until they have completed their participation in the distribution.
Listing
and Transfer Agent
Our
Class B common stock is listed on Nasdaq and trades under the symbol “RR.” The transfer agent for our Class B common stock
is Continental Stock Transfer & Trust Company. There is no established public trading market for the Warrants or the Pre-Funded Warrants,
and we do not plan on making an application to list the Warrants or the Pre-Funded Warrants on Nasdaq, any national securities exchange
or other nationally recognized trading system. We will act as the registrar and transfer agent for the Warrants and the Pre-Funded Warrants.
Electronic
Distribution
This
prospectus in electronic format may be made available on websites or through other online services maintained by the Placement Agent,
or by its affiliates. Other than this prospectus in electronic format, the information on the Placement Agent’s website and any
information contained in any other website maintained by the Placement Agent is not part of this prospectus or the registration statement
of which this prospectus forms a part, has not been approved and/or endorsed by us or the Placement Agent in its capacity as a Placement
Agent, and should not be relied upon by investors.
INCORPORATION
OF CERTAIN INFORMATION BY REFERENCE
The
SEC allows us to “incorporate by reference” the information we file with them. This means that we can disclose important
information to you by referring you to those documents instead of having to repeat the information in this document. The information
incorporated by reference is considered to be part of this prospectus, and later information that we file with the SEC will automatically
update and supersede this information. We incorporate by reference the documents listed below and any future filings made with the SEC
under Sections 13(a), 13(c), 14 or 15(d) of the Exchange Act (1) after the date of the initial registration statement,
as amended, and prior to effectiveness of the registration statement, and (2) after the date of this prospectus and prior to the
termination of this offering. Such information will automatically update and supersede the information contained in this prospectus and
the documents listed below:
| (a) | Our
Annual Report on Form 10-K for the year ended September 30, 2023 filed
with the SEC on January 11,
2024 (as amended by Amendment No. 1 to Annual Report on Form 10-K/A on March 27,
2024); |
| (c) | Our
Current Reports on Form 8-K filed with the SEC on November 22, 2023, December 29,
2023, February 21,
2024 (as amended by Current Report on Form 8-K/A on March 15,
2024), March 15,
2024, March 22,
2024 and April
23, 2024; and |
| (d) | The
description of our Class B common stock, which is contained in the Registration Statement
on Form 8-A,
filed with the SEC on November 13, 2023, and including any amendments or reports filed
for the purpose of updating such description. |
All
documents subsequently filed by the registrant pursuant to Sections 13(a), 13(c), 14 or 15(d) of the Exchange Act, prior to
the termination of the offering shall be deemed to be incorporated by reference into the prospectus. Any statement contained herein or
in a document incorporated or deemed to be incorporated herein by reference shall be deemed to be modified or superseded for purposes
of this prospectus to the extent that a statement contained herein or in any other subsequently filed document which also is or is deemed
to be incorporated herein by reference modifies or supersedes such statement.
Notwithstanding
the foregoing, information that we elect to furnish, but not file, or have furnished, but not filed, with the SEC in accordance with
SEC rules and regulations is not incorporated into this registration statement, shall not be deemed “filed” under the Securities
Act, and does not constitute a part hereof.
We
will provide to each person, including any beneficial owner, to whom a copy of this prospectus is delivered, a copy of any or all of
the information that we have incorporated by reference into this prospectus but not delivered with this prospectus. We will provide this
information upon written or oral request at no cost to the requester. You may request this information by contacting our corporate headquarters
at the following address: 4175 Cameron St Ste 1, Las Vegas, NV 89103, Attn: Zhenqiang (Michael) Huang, or by calling (866) 236-3835 or
at the following email address: ir@richtechrobotics.com. We maintain a website at www.richtechrobotics.com. You may access
our annual reports on Form 10-K, quarterly reports on Form 10-Q, current reports on Form 8-K and amendments to those
reports filed or furnished pursuant to Section 13(a) or 15(d) of the Exchange Act with the SEC free of charge at
our website as soon as reasonably practicable after such material is electronically filed with, or furnished to, the SEC. The information
contained in, or that can be accessed through, our website is not incorporated by reference in, and is not part of, this prospectus.
WHERE
YOU CAN FIND MORE INFORMATION
We
have filed with the SEC a registration statement on Form S-1 under the Securities Act with respect to the shares of Class B
common stock offered hereby. This prospectus, which constitutes a part of the registration statement, does not contain all of the information
set forth in the registration statement or the exhibits filed therewith. For further information about us and the Class B common
stock offered hereby, reference is made to the registration statement and the exhibits filed therewith. Statements contained in this
prospectus concerning the contents of any contract or any other document are not necessarily complete, please see the copy of the contract
or document that has been filed for the complete contents of that contract or document. Each statement in this prospectus relating to
a contract or document filed as an exhibit is qualified in all respects by the filed exhibit. The exhibits to the registration statement
should be reviewed for the complete contents of these contracts and documents. A copy of the registration statement and its exhibits
may be obtained from the SEC upon the payment of fees prescribed by it. The SEC maintains a website that contains reports, proxy and
information statements and other information regarding registrants that file electronically with the SEC. The address of the website
is www.sec.gov.
We
are subject to the information and periodic and current reporting requirements of the Exchange Act, and in accordance therewith,
file periodic and current reports, proxy statements and other information with the SEC. The registration statement, such periodic
and current reports and other information can be obtained electronically by means of the SEC’s website at www.sec.gov.
We
also maintain a website at www.richtechrobotics.com. you may access these materials at our website free of charge as soon
as reasonably practicable after they are electronically filed with, or furnished to, the SEC. Information contained in, or that
can be accessed through, our website is not a part of, and is not incorporated into, this prospectus.
LEGAL
MATTERS
The
validity of the securities offered hereby will be passed upon for us by Ellenoff Grossman & Schole LLP, New York, NY. Certain legal
matters will be passed upon for the Placement Agent by Haynes and Boone, LLP, New York, New York.
EXPERTS
Our
audited consolidated financial statements as of September 30, 2023 and 2022 and for the two years then ended have been incorporated
by reference into this prospectus and the registration statement of which it forms a part in reliance upon the report of Bush &
Associates CPA, independent registered public accounting firm and upon the report of such firm given upon the authority of said firm
as experts in accounting and auditing.
DISCLOSURE
OF COMMISSION POSITION ON INDEMNIFICATION FOR SECURITIES ACT LIABILITIES
In
the opinion of the SEC, indemnification for liabilities arising under the Securities Act is against public policy as expressed in the
Securities Act and is, therefore, unenforceable. Insofar as indemnification for liabilities arising under the Securities Act may be permitted
to directors, officers or persons controlling the registrant pursuant to the foregoing provisions, the registrant has been informed that
in the opinion of the SEC such indemnification is against public policy as expressed in the Securities Act and is therefore unenforceable.
13,242,963 Shares of Class B Common Stock
Pre-Funded Warrants to Purchase up to 2,312,594
Shares of Class B Common Stock
Warrants to Purchase up to 15,555,557 Shares
of Class B Common Stock
Placement Agent Warrants to Purchase up to 1,088,889
Shares of Class B Common Stock
Up to 18,957,040 Shares of Class B Common Stock
Issuable Upon Exercise of the Pre-Funded Warrants,
Warrants and Placement Agent Warrants
RICHTECH
ROBOTICS INC.
PROSPECTUS
Rodman
& Renshaw LLC
The
date of this prospectus is August 29, 2024.
Richtech Robotics (NASDAQ:RR)
Historical Stock Chart
From Sep 2024 to Oct 2024
Richtech Robotics (NASDAQ:RR)
Historical Stock Chart
From Oct 2023 to Oct 2024